<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Psychol</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Psychol</journal-id>
<journal-id journal-id-type="publisher-id">Front. Psychol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Psychology</journal-title>
</journal-title-group>
<issn pub-type="epub">1664-1078</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30984083</article-id>
<article-id pub-id-type="pmc">6450211</article-id>
<article-id pub-id-type="doi">10.3389/fpsyg.2019.00691</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Psychology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Cognitive Control as a 5-HT<sub>1A</sub>-Based Domain That Is Disrupted in Major Depressive Disorder</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Langenecker</surname>
<given-names>Scott A.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<xref ref-type="author-notes" rid="fn002">
<sup>†</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/241485/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mickey</surname>
<given-names>Brian J.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn002">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Eichhammer</surname>
<given-names>Peter</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/12705/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sen</surname>
<given-names>Srijan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Elverman</surname>
<given-names>Kathleen H.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kennedy</surname>
<given-names>Susan E.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/685953/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Heitzeg</surname>
<given-names>Mary M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ribeiro</surname>
<given-names>Saulo M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Love</surname>
<given-names>Tiffany M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn002">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hsu</surname>
<given-names>David T.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/131112/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Koeppe</surname>
<given-names>Robert A.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/662001/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Watson</surname>
<given-names>Stanley J.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Akil</surname>
<given-names>Huda</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/13666/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Goldman</surname>
<given-names>David</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Burmeister</surname>
<given-names>Margit</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/8064/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zubieta</surname>
<given-names>Jon-Kar</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn002">
<sup>†</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/11919/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>The Molecular &amp; Behavioral Neuroscience Institute, University of Michigan</institution>, <addr-line>Ann Arbor, MI</addr-line>, <country>United States</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Psychiatry, University of Michigan</institution>, <addr-line>Ann Arbor, MI</addr-line>, <country>United States</country></aff>
<aff id="aff3"><sup>3</sup><institution>National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health</institution>, <addr-line>Bethesda, MD</addr-line>, <country>United States</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Roger Ho, National University of Singapore, Singapore</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Cyrus S. H. Ho, National University Health System, Singapore; Yanxia Lu, Agency for Science, Technology and Research (A<sup>∗</sup>STAR), Singapore; Agnieszka Anna Olszewska-Guizzo, National University of Singapore, Singapore Syeda Fabeha Husain contributed to the review of Agnieszka Anna Olszewska-Guizzo</p>
</fn>
<corresp id="c001">*Correspondence: Scott A. Langenecker, <email>s.langenecker@hsc.utah.edu</email></corresp>
<fn fn-type="other" id="fn002">
<p><sup>†</sup>Present address: Scott A. Langenecker, Brian J. Mickey, Tiffany M. Love, and Jon-Kar Zubieta, Department of Psychiatry, University of Utah, Salt Lake City, UT, United States</p>
</fn>
<fn fn-type="other" id="fn003">
<p>This article was submitted to Emotion Science, a section of the journal Frontiers in Psychology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>29</day>
<month>3</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>10</volume>
<elocation-id>691</elocation-id>
<history>
<date date-type="received">
<day>07</day>
<month>12</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>12</day>
<month>3</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2019 Langenecker, Mickey, Eichhammer, Sen, Elverman, Kennedy, Heitzeg, Ribeiro, Love, Hsu, Koeppe, Watson, Akil, Goldman, Burmeister and Zubieta.</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>Langenecker, Mickey, Eichhammer, Sen, Elverman, Kennedy, Heitzeg, Ribeiro, Love, Hsu, Koeppe, Watson, Akil, Goldman, Burmeister and Zubieta</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Heterogeneity within Major Depressive Disorder (MDD) has hampered identification of biological markers (e.g., intermediate phenotypes, IPs) that might increase risk for the disorder or reflect closer links to the genes underlying the disease process. The newer characterizations of dimensions of MDD within Research Domain Criteria (RDoC) domains may align well with the goal of defining IPs. We compare a sample of 25 individuals with MDD compared to 29 age and education matched controls in multimodal assessment. The multimodal RDoC assessment included the primary IP biomarker, positron emission tomography (PET) with a selective radiotracer for 5-HT<sub>1A</sub> [(11C)WAY-100635], as well as event-related functional MRI with a Go/No-go task targeting the Cognitive Control network, neuropsychological assessment of affective perception, negative memory bias and Cognitive Control domains. There was also an exploratory genetic analysis with the serotonin transporter (5-HTTLPR) and monamine oxidase A (MAO-A) genes. In regression analyses, lower 5-HT<sub>1A</sub> binding potential (BP) in the MDD group was related to diminished engagement of the Cognitive Control network, slowed resolution of interfering cognitive stimuli, one element of Cognitive Control. In contrast, higher/normative levels of 5-HT<sub>1A</sub> BP in MDD (only) was related to a substantial memory bias toward negative information, but intact resolution of interfering cognitive stimuli and greater engagement of Cognitive Control circuitry. The serotonin transporter risk allele was associated with lower 1a BP and the corresponding imaging and cognitive IPs in MDD. Lowered 5HT 1a BP was present in half of the MDD group relative to the control group. Lowered 5HT 1a BP may represent a subtype including decreased engagement of Cognitive Control network and impaired resolution of interfering cognitive stimuli. Future investigations might link lowered 1a BP to neurobiological pathways and markers, as well as probing subtype-specific treatment targets.</p>
</abstract>
<kwd-group>
<kwd>positron emission tomography</kwd>
<kwd>intermediate cognitive phenotypes</kwd>
<kwd>major depressive disorder</kwd>
<kwd>serotonin</kwd>
<kwd>executive functioning</kwd>
<kwd>interference resolution</kwd>
<kwd>processing speed</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">National Institute of Mental Health<named-content content-type="fundref-id">10.13039/100000025</named-content></funding-source>
</award-group>
<award-group>
<funding-source id="cn002">National Alliance for Research on Schizophrenia and Depression<named-content content-type="fundref-id">10.13039/100009670</named-content></funding-source>
</award-group>
</funding-group>
<counts>
<fig-count count="5"></fig-count>
<table-count count="2"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="151"></ref-count>
<page-count count="16"></page-count>
<word-count count="0"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec>
<title>Introduction</title>
<p>An enduring, but incomplete observation in MDD (Major Depressive Disorder) is of serotonin dysfunction. Serotonin dysfunction is a corollary of the monoamine hypothesis, positing that MDD is associated with relative depletion of monoamines including catecholamines (e.g., dopamine and noradrenaline) and tryptamine (e.g., serotonin) (<xref ref-type="bibr" rid="B144">Wijaya et al., 2018</xref>). Parallel and sometimes convergent reports spanning neurochemistry, behavioral pharmacology, neuroimaging and gene have implicated serotonergic dysfunction in MDD. However, while such dysfunction can be thought of as a typical, it is very clearly not a universal characteristic of MDD (<xref ref-type="bibr" rid="B2">Albert and Lemonde, 2004</xref>; <xref ref-type="bibr" rid="B50">Kalia, 2005</xref>; <xref ref-type="bibr" rid="B133">Surtees et al., 2006</xref>). Evidence that serotonin function is relevant in a subset of those with MDD includes a number of different avenues of exploration. First, affective experience and emotional regulation are more dramatically altered after acute tryptophan depletion (ATD), more so in persons with personal or family history of MDD (<xref ref-type="bibr" rid="B113">Rogers et al., 2003</xref>; <xref ref-type="bibr" rid="B28">Fusar-Poli et al., 2006</xref>; <xref ref-type="bibr" rid="B95">Neumeister et al., 2006</xref>; <xref ref-type="bibr" rid="B130">Spring et al., 2007</xref>; <xref ref-type="bibr" rid="B138">van der Veen et al., 2007</xref>). Second, selective serotonergic reuptake inhibitors (SSRIs) are more effective than placebo in a majority of controlled clinical trials (<xref ref-type="bibr" rid="B116">Rush et al., 2006</xref>; <xref ref-type="bibr" rid="B137">Trivedi et al., 2006</xref>). Third, functional loci at genes that mediate serotonergic function have been implicated in MDD both alone, and via interaction with early life stress (<xref ref-type="bibr" rid="B36">Hariri et al., 2002</xref>, <xref ref-type="bibr" rid="B35">2006</xref>; <xref ref-type="bibr" rid="B124">Sen et al., 2004</xref>; <xref ref-type="bibr" rid="B95">Neumeister et al., 2006</xref>; <xref ref-type="bibr" rid="B133">Surtees et al., 2006</xref>; <xref ref-type="bibr" rid="B29">Gotlib et al., 2008</xref>; <xref ref-type="bibr" rid="B86">Mak et al., 2013</xref>). Fourth, some of these functional variants in genes (modulating serotonin function) alter brain responses to emotion and brain connectivity (<xref ref-type="bibr" rid="B21">Dannlowski et al., 2008</xref>; <xref ref-type="bibr" rid="B51">Kalin et al., 2008</xref>; <xref ref-type="bibr" rid="B26">Elton et al., 2014</xref>; <xref ref-type="bibr" rid="B143">Wessa and Lois, 2015</xref>). These alternations align with a model of how inherited variations contribute to risk for MDD. Fifth, manipulations of serotonin function and/or use of agents with serotonergic effects within animal models can simulate depression and anxiety-like behaviors (<xref ref-type="bibr" rid="B2">Albert and Lemonde, 2004</xref>; <xref ref-type="bibr" rid="B7">Bert et al., 2008</xref>; <xref ref-type="bibr" rid="B10">Borg, 2008</xref>). Sixth, depression is associated with negative cognitive changes including memory and executive function impairments (<xref ref-type="bibr" rid="B13">Burt et al., 1995</xref>; <xref ref-type="bibr" rid="B128">Snyder, 2013</xref>; <xref ref-type="bibr" rid="B149">Yu et al., 2018</xref>), negative affect related to control, success, and rejection (<xref ref-type="bibr" rid="B148">Yeo et al., 2017</xref>) and increased negative schema (<xref ref-type="bibr" rid="B131">Stange et al., 2017</xref>; <xref ref-type="bibr" rid="B76">Lim et al., 2018</xref>). As such, there is continuing pursuit of domains affected in MDD that can be linked to serotonergic function and genes. There is also interest in whether these dimensional features may define a more homogeneous subset for further exploration and targeted treatment. A short review of the relevant links of serotonin dysfunction in MDD and of potential multimodal intermediate phenotypes [IPs (<xref ref-type="bibr" rid="B12">Burmeister et al., 2008</xref>; <xref ref-type="bibr" rid="B51">Kalin et al., 2008</xref>; <xref ref-type="bibr" rid="B134">Tan et al., 2008</xref>; <xref ref-type="bibr" rid="B72">Langenecker et al., 2010</xref>; <xref ref-type="bibr" rid="B142">Webb et al., 2016</xref>)] is conducted to integrate these separate lines of inquiry.</p>
<sec>
<title>Imaging Studies of 5-HT<sub>1A</sub> Function</title>
<p>Evidence of abnormal 5-HT (5-hydroxytyptamine refers to G protein coupled receptors and ligand-gated ion channels, also known as serotonin receptors) function in MDD is building, including for 5-HT<sub>1A</sub> specifically (<sub>1A</sub> is a subtype of 5-HT receptor which is the most widespread 5-HT receptor, including within cortex and medial temporal structures). Past human imaging studies of 5-HT<sub>1A</sub> binding potential (BP) have focused on areas of binding where serotonin receptors are more densely populated, including the raphe, as well as frontal, cingulate and medial temporal cortices (<xref ref-type="bibr" rid="B87">Marazziti et al., 1994</xref>; <xref ref-type="bibr" rid="B100">Oquendo et al., 2003</xref>; <xref ref-type="bibr" rid="B102">Parsey et al., 2006</xref>, <xref ref-type="bibr" rid="B101">2010</xref>; <xref ref-type="bibr" rid="B24">Drevets et al., 2007</xref>; <xref ref-type="bibr" rid="B123">Selvaraj et al., 2017</xref>; <xref ref-type="bibr" rid="B58">Kranz et al., 2018</xref>). 5-HT<sub>1A</sub> receptors regulate the firing of 5-HT neurons presynaptically in the raphe nuclei and are expressed postsynaptically in many different cortical and subcortical brain regions (<xref ref-type="bibr" rid="B122">Schlumpf et al., 1987</xref>; <xref ref-type="bibr" rid="B53">Kaufman et al., 2015</xref>; <xref ref-type="bibr" rid="B150">Zanderigo et al., 2018</xref>). In the cortex, there are inhibitory properties of the postsynaptic 5-HT<sub>1A</sub> receptors (<xref ref-type="bibr" rid="B30">Gross et al., 2002</xref>; <xref ref-type="bibr" rid="B10">Borg, 2008</xref>), plus regulation of the release of glutamate in subcortical structures (<xref ref-type="bibr" rid="B20">Czyrak et al., 2003</xref>). A recent review of concentrations of transporter (5HTT), 5-HT<sub>1A</sub>, and 5-HT<sub>2A</sub> receptors reflect the fact that 5-HTTs are densely populated in subcortical, pre-synaptic regions, whereas, 5-HT<sub>1A</sub> and 5-HT<sub>2A</sub> receptors are more dense in cortical regions (<xref ref-type="bibr" rid="B59">Kranz et al., 2010</xref>; <xref ref-type="bibr" rid="B54">Kautzky et al., 2018</xref>). These same cortical areas support a number of cognitive and affective processes and both the regions and the processes they support are heavily implicated in MDD (<xref ref-type="bibr" rid="B136">Teasdale and Dent, 1987</xref>; <xref ref-type="bibr" rid="B37">Heller and Nitschke, 1998</xref>; <xref ref-type="bibr" rid="B43">Hugdahl et al., 2003</xref>; <xref ref-type="bibr" rid="B104">Phillips et al., 2003</xref>, <xref ref-type="bibr" rid="B105">2008</xref>; <xref ref-type="bibr" rid="B24">Drevets et al., 2007</xref>; <xref ref-type="bibr" rid="B66">Langenecker et al., 2007c</xref>, <xref ref-type="bibr" rid="B72">2010</xref>, <xref ref-type="bibr" rid="B68">2014</xref>; <xref ref-type="bibr" rid="B108">Porter et al., 2007</xref>; <xref ref-type="bibr" rid="B23">Disner et al., 2011</xref>).</p>
<p>Positron emission tomography (PET) studies, typically utilizing the selective radiotracer for 5-HT<sub>1A</sub> receptors, <sup>[11C]</sup>WAY-100635, have noted lowered levels of 5-HT<sub>1A</sub> receptor availability (BP<sub>ND</sub>) within these regions in MDD as well as alterations in 5-HT<sub>1A</sub> availability pre- and post-treatment (<xref ref-type="bibr" rid="B8">Bhagwagar et al., 2004</xref>; <xref ref-type="bibr" rid="B24">Drevets et al., 2007</xref>; <xref ref-type="bibr" rid="B92">Moses-Kolko et al., 2007</xref>; <xref ref-type="bibr" rid="B39">Hirvonen et al., 2008</xref>; <xref ref-type="bibr" rid="B55">Kautzky et al., 2017</xref>). Lowered 5-HT<sub>1A</sub> BP in MDD is the general pattern observed; however, utilizing arterial sampling or a cortical reference region can make a significant impact on the direction of effects [higher or lower (<xref ref-type="bibr" rid="B24">Drevets et al., 2007</xref>; <xref ref-type="bibr" rid="B101">Parsey et al., 2010</xref>)]. As such, careful verification of reference region/marker equivalence between MDD and healthy comparison (HC) groups is important for PET studies with this radiotracer. Lower brainstem SERT BP was reported in an additional study of depressed suicide attempters (<xref ref-type="bibr" rid="B98">Nye et al., 2013</xref>). 5-HT<sub>1A</sub> disruptions have also been reported in high-risk offspring of those with MDD (<xref ref-type="bibr" rid="B90">Milak et al., 2018</xref>).</p>
</sec>
<sec>
<title>Animal Models of 5-HT<sub>1A</sub> in MDD</title>
<p>Given the limited number and variability across human <italic>in vivo</italic> studies, we briefly review the role of 5-HT<sub>1A</sub> in the pathophysiology of MDD as seen in animal models of depression and human postmortem studies. Animal studies have primarily reported increased 5-HT<sub>1A</sub> function after chronic SSRI administration (<xref ref-type="bibr" rid="B32">Haddjeri et al., 1998</xref>) and increases in anxious and depressive behaviors after 5-HT<sub>1A</sub> blockade, depletion, or knockout (<xref ref-type="bibr" rid="B99">Olivier et al., 2001</xref>;<xref ref-type="bibr" rid="B1">Akil, 2005</xref>; <xref ref-type="bibr" rid="B151">Zhang et al., 2006</xref>; <xref ref-type="bibr" rid="B111">Richardson et al., 2010</xref>). Novel antidepressants including agomelatine and vortioxetine induced modulation of brain-derived neurotrophic factor (BDNF) which is a neurotrophin that serves as a survival factor for neurons (<xref ref-type="bibr" rid="B84">Lu et al., 2018a</xref>,<xref ref-type="bibr" rid="B85">b</xref>). In a related study, BDNF knock out mice showed a significant attenuation of 5-HT<sub>1A</sub> receptor function (<xref ref-type="bibr" rid="B38">Hensler et al., 2007</xref>). Acute stress results in decreased 5-HT<sub>1A</sub> mRNA in the hippocampus (<xref ref-type="bibr" rid="B81">Lopez et al., 1999</xref>) and those with knockout or blockade demonstrate memory dysfunction (<xref ref-type="bibr" rid="B120">Sarnyai et al., 2000</xref>). Animals with 5-HT<sub>1A</sub> antagonist acute injection into the dorsal raphe show enhanced social defeat behavior (<xref ref-type="bibr" rid="B17">Cooper et al., 2008</xref>).</p>
<p>Stress-sensitive cynomolgus monkeys exhibit a reduced number of 5-HT<sub>1A</sub> receptors in dorsal raphe after stress exposure (<xref ref-type="bibr" rid="B77">Lima et al., 2009</xref>). Similarly, exposure to peer-rearing in rhesus monkeys as an early life stressor generally results in lower <italic>in vivo</italic> 5-HT<sub>1A</sub> receptor concentrations (<xref ref-type="bibr" rid="B129">Spinelli et al., 2009</xref>). Likewise, chronic psychosocial stress in tree shrews results in decreased 5-HT<sub>1A</sub> receptors in prefrontal cortex, hippocampus, and parietal cortex (<xref ref-type="bibr" rid="B27">Flugge, 1995</xref>).</p>
</sec>
<sec>
<title>Human Postmortem and Anatomical Studies</title>
<p>Furthermore, in human postmortem studies, lower hippocampal 5-HT<sub>1A</sub> mRNA is demonstrated in MDD subjects, with death by accident, assault, suicide, or cardiac causes (<xref ref-type="bibr" rid="B80">Lopez et al., 1998</xref>) and reduced 5-HT<sub>1A</sub> receptors in amygdala and hippocampus in suicide completers (<xref ref-type="bibr" rid="B15">Cheetham et al., 1990</xref>). Finally, 5-HT<sub>1A</sub> receptor density is related to gray matter volume cortical thickness in many prefrontal and parietal regions in HCs, but not in MDD (<xref ref-type="bibr" rid="B107">Pillai et al., 2018</xref>; <xref ref-type="bibr" rid="B150">Zanderigo et al., 2018</xref>). Notably, one recent study used PET binding to subdivide clusters in 5-HT function for anatomical parcellation and alignment with resting state networks (<xref ref-type="bibr" rid="B54">Kautzky et al., 2018</xref>). Both 5-HT<sub>1A</sub> and 5-HT<sub>2A</sub> demonstrate cortical; distribution and alignment with dorsal attention and frontoparietal networks (clusters 2 and 3), suggesting that is alignment between monamine function and cortical networks.</p>
</sec>
<sec>
<title>Tryptophan Depletion and Effects on Cognitive Control and Related Functions in MDD</title>
<p>A potentially convergent line of study is a possibility that divergent serotonergic function for some individuals with MDD is related to abnormalities in executive function and affective processing – these are broad domains within Research Domain Criteria [RDoC (<xref ref-type="bibr" rid="B19">Cuthbert, 2005</xref>)] that may constitute IPs for MDD. Executive functioning domains include conceptual reasoning, inhibitory control, verbal fluency, interference resolution, working memory – components of the Cognitive Control network. Difficulties in these skills are present in MDD (<xref ref-type="bibr" rid="B5">Austin et al., 1999</xref>; <xref ref-type="bibr" rid="B14">Channon and Green, 1999</xref>; <xref ref-type="bibr" rid="B112">Rogers et al., 2004</xref>; <xref ref-type="bibr" rid="B65">Langenecker et al., 2007b</xref>; <xref ref-type="bibr" rid="B128">Snyder, 2013</xref>) and lead to work-related disability and productivity loss (<xref ref-type="bibr" rid="B73">Lee et al., 2018</xref>). Links between these executive function skills (and cognitive control network function) and serotonergic function are conducted by reducing synthesis of 5-HT centrally via ATD (<xref ref-type="bibr" rid="B61">Lamar et al., 2009</xref>; <xref ref-type="bibr" rid="B127">Smith et al., 1999</xref>). ATD has also been shown to result in disrupted affective processing and networks (<xref ref-type="bibr" rid="B104">Phillips et al., 2003</xref>), increasing negative emotional experience and decreases in positive affective experience [<xref ref-type="bibr" rid="B114">Roiser et al., 2007</xref>; <xref ref-type="bibr" rid="B130">Spring et al., 2007</xref>; <xref ref-type="bibr" rid="B138">van der Veen et al., 2007</xref>]. ATD also disrupts social cooperation (<xref ref-type="bibr" rid="B146">Wood et al., 2006</xref>). Some affective domains of interest for MDD are enhanced memory for negative information and disrupted accuracy in processing of facial emotions [<xref ref-type="bibr" rid="B31">Gur et al., 1992</xref>; <xref ref-type="bibr" rid="B63">Langenecker et al., 2005</xref>, <xref ref-type="bibr" rid="B65">2007b</xref>; <xref ref-type="bibr" rid="B42">Hsu et al., 2010</xref>].</p>
<p>In summary, there is a distinct possibility that disrupted 5-HT<sub>1A</sub> receptor mediated mechanisms might translate to affective and cognitive domains of dysfunction for MDD. Multimodal studies, encouraged by RDoC, can address convergence of multiple different assays. Here, we hypothesized that lower 5-HT<sub>1A</sub> BP in MDD [Hypothesis (Hyp) 1] maybe related to dysfunction in affective (bottom-up, Hyp 2) and executive (top-down, Hyp 3) domains (<xref ref-type="bibr" rid="B72">Langenecker et al., 2010</xref>, <xref ref-type="bibr" rid="B68">2014</xref>; <xref ref-type="bibr" rid="B23">Disner et al., 2011</xref>). These affective dysfunction domains included negative memory bias, (<xref ref-type="bibr" rid="B11">Bradley et al., 1996</xref>; <xref ref-type="bibr" rid="B42">Hsu et al., 2010</xref>) and impaired emotion categorization (<xref ref-type="bibr" rid="B31">Gur et al., 1992</xref>; <xref ref-type="bibr" rid="B63">Langenecker et al., 2005</xref>, <xref ref-type="bibr" rid="B65">2007b</xref>). We used executive dysfunction domains - previously identified factors in individuals with bipolar disease, similar to domains reported in MDD (<xref ref-type="bibr" rid="B112">Rogers et al., 2004</xref>; <xref ref-type="bibr" rid="B128">Snyder, 2013</xref>). These factors do not align perfectly with the RDoC domains within Cognitive Systems, although we note that the RDoC domains are suggestive and not prescriptive (<xref ref-type="bibr" rid="B45">Insel et al., 2010</xref>; <xref ref-type="bibr" rid="B119">Sanislow et al., 2010</xref>). The broader goal is to utilize dimensional, factor-driven analysis in studies where these are experimentally advantageous over DSM categories. Here, Cognitive Control subsumes the elements of (1) speed (Verbal Fluency and Processing Speed), (2) speed in the context of distracting or competing stimuli (Processing Speed with Interference Resolution), (3) stopping a prepotent response (e.g., regulation, here Inhibitory Control), and (4) balance of decision making within multistimulus sets and changing rules (Conceptual Reasoning and Set-Shifting) (<xref ref-type="bibr" rid="B72">Langenecker et al., 2010</xref>; <xref ref-type="bibr" rid="B117">Ryan et al., 2013</xref>).</p>
<p>We further investigated relationships of fMRI BOLD responses during a Cognitive Control task based upon 5-HT<sub>1A</sub> BP in the MDD sample, including fMRI BOLD responses based upon degree of 5-HT<sub>1A</sub> BP<sub>ND</sub> in the MDD sample [Hyp 4 of lowered 5-HT<sub>1A</sub> BP<sub>ND</sub> correlated with lowered activation in Cognitive Control region(s)]. Cross-modality comparisons are relatively rare in MDD (multimodal imaging can be simultaneous or on separate days), but they illustrate the value in integrating localization, function, and neurotransmitter density (<xref ref-type="bibr" rid="B51">Kalin et al., 2008</xref>; <xref ref-type="bibr" rid="B123">Selvaraj et al., 2017</xref>; <xref ref-type="bibr" rid="B33">Hamilton et al., 2018</xref>; <xref ref-type="bibr" rid="B58">Kranz et al., 2018</xref>; <xref ref-type="bibr" rid="B106">Piel et al., 2018</xref>). Analyses were also conducted with the HC group to verify the general or MDD specific nature of these relationships (Hyp 5). Exploratory analyses with genetic variants related to serotonergic function were also conducted (Hyp 6) (<xref ref-type="bibr" rid="B145">Wojnar et al., 2009</xref>; <xref ref-type="bibr" rid="B140">Villafuerte et al., 2009</xref>; <xref ref-type="bibr" rid="B86">Mak et al., 2013</xref>; <xref ref-type="bibr" rid="B55">Kautzky et al., 2017</xref>; <xref ref-type="bibr" rid="B97">Norgaard et al., 2017</xref>; <xref ref-type="bibr" rid="B106">Piel et al., 2018</xref>; <xref ref-type="bibr" rid="B150">Zanderigo et al., 2018</xref>).</p>
</sec>
</sec>
<sec id="s1" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec>
<title>Participants</title>
<p>Twenty-nine HC and 25 patients with MDD were recruited via newspaper advertisements, campus fliers, and word of mouth with Institutional Review Board (IRB)–approved written informed consent consistent with the Declaration of Helsinki at the University of Michigan. Diagnosis was confirmed with the Structured Clinical Interview for Diagnostic and Statistical Manual [DSM-IV (<xref ref-type="bibr" rid="B3">American Psychiatric Association, 1994</xref>)]. HC subjects were required to be below 5 and MDD subjects above 15 on the Hamilton Rating Scale for Depression for study entry [HRSD, 17 item scale (<xref ref-type="bibr" rid="B34">Hamilton, 1960</xref>)], using conservative thresholds for sensitivity and specificity (<xref ref-type="bibr" rid="B93">Naarding et al., 2002</xref>; <xref ref-type="bibr" rid="B115">Romera et al., 2011</xref>; <xref ref-type="bibr" rid="B121">Sawamura et al., 2018</xref>). The groups did not differ in age, sex, years of formal education, or intellectual ability [(<xref ref-type="bibr" rid="B125">Shipley, 1946</xref>), all <italic>p</italic>’s &gt; 0.15, <xref ref-type="table" rid="T1">Table 1</xref>]. Other evidence of neurological or psychiatric disorders, other than generalized anxiety and/or social/specific phobia, panic disorder in the MDD sample was exclusionary. Cigarette smokers and those with alcohol abuse or who had used illegal drugs in the past 2 years were excluded. Patients with MDD were unmedicated and had been medication-free for a minimum of 6 months for all potentially psychoactive medications (mean 25.7 months, 14 medication naïve).</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Demographic and clinical information for participants with major depressive disorder and matching healthy control adults.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<th align="center" colspan="1" rowspan="1" valign="top">MDD (<italic>N</italic> = 25)</th>
<th align="center" colspan="1" rowspan="1" valign="top">HC (<italic>N</italic> = 29)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Age</td>
<td align="center" colspan="1" rowspan="1" valign="top">39.7 (11.0)</td>
<td align="center" colspan="1" rowspan="1" valign="top">37.8 (11.8)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Education</td>
<td align="center" colspan="1" rowspan="1" valign="top">15.0 (2.9)</td>
<td align="center" colspan="1" rowspan="1" valign="top">16.1 (2.3)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Shipley estimated IQ</td>
<td align="center" colspan="1" rowspan="1" valign="top">101.8 (13.1)</td>
<td align="center" colspan="1" rowspan="1" valign="top">105.6 (12.1)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Sex</td>
<td align="center" colspan="1" rowspan="1" valign="top">14F, 11 M</td>
<td align="center" colspan="1" rowspan="1" valign="top">18 F, 11M</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">HDRS-17<sup>∗</sup></td>
<td align="center" colspan="1" rowspan="1" valign="top">19.0 (2.6)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.9 (1.4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Suicide item (0–4)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.5 (0.9)</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Neuroticism<sup>∗</sup></td>
<td align="center" colspan="1" rowspan="1" valign="top">60.3 (11.2)</td>
<td align="center" colspan="1" rowspan="1" valign="top">40.2 (9.6)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Comorbid anxiety Dx</td>
<td align="center" colspan="1" rowspan="1" valign="top">11 (44%)</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<attrib>
<italic><sup>∗</sup>Groups differ at <italic>p</italic> &lt; 0.05. Social anxiety (<italic>n</italic> = 7), PTSD (<italic>n</italic> = 2), panic (<italic>n</italic> = 2), generalized anxiety (<italic>n</italic> = 1). HDRS, hamilton depression rating scale. <italic>T</italic>-tests were used to compare groups for age, education, estimated IQ, HDRS, neuroticism. Chi-square was used to compare groups by sex distribution.</italic>
</attrib>
</table-wrap-foot>
</table-wrap>
</sec>
<sec>
<title>Overall Procedure</title>
<p>Neuropsychological measures were typically captured within several days after the intake and diagnosis. fMRI and PET were collected on average 9.5 days (<italic>SD</italic> = 36.8) apart for participants. The SD is large because 2 MDD and 2 HC participants discontinued and then restarted the study about 3–4 months apart. 85% of participants completed all evaluations within 1 month.</p>
</sec>
<sec>
<title>PET Scanning and Processing Procedures</title>
<p>Positron emission tomography scanning was conducted using [<sup>11</sup>C]Way100635. PET procedures were similar to those described previously (<xref ref-type="bibr" rid="B89">Mickey et al., 2008</xref>). PET images were acquired with a Siemens/CTI HR<sup>+</sup> scanner in three-dimensional mode with septa retracted. [carbonyl- 11C]WAY-100635, a specific 5-HT<sub>1A</sub> receptor antagonist, was synthesized at high specific activity (<xref ref-type="bibr" rid="B44">Hwang et al., 1999</xref>). The tracer was administered as a bolus followed by continuous infusion to more rapidly achieve steady-state conditions. Eighteen scans of increasing duration (0.5–10 min) were acquired over a period of 90 min. Raw PET images were co-registered and smoothed with a Gaussian filter (4 mm FWHM). Smoothed images were transformed voxel-by-voxel into parametric maps of tracer transport (K<sub>1</sub> ratio) and specific binding [distribution volume ratio (DVR)] using a modified Logan graphical analysis, with bilateral cerebellar white matter (excluding the vermis) as the reference region (<xref ref-type="bibr" rid="B78">Logan et al., 1996</xref>). Non-displaceable binding potential (BP<sub>ND</sub>) was defined as BP<sub>ND</sub> = DVR-1 = k<sub>2</sub>B<sub>max</sub>/K<sub>D</sub>, where B<sub>max</sub> is the total receptor concentration, K<sub>D</sub> is the dissociation constant, and k<sub>2</sub> is the extracellular concentration of tracer (assumed to be a small and constant value) (<xref ref-type="bibr" rid="B131">Stange et al., 2017</xref>). Two individuals (one control and one MDD) showed visible binding in the cerebellum and (as a result) anomalously low global BP<sub>ND</sub> (2.4–3.0 SDs below the mean, illustrated in <xref ref-type="fig" rid="F1">Figure 1</xref>), and were excluded.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Figure illustrating the 5-HT<sub>1A</sub> BP values in the deep white matter (DWM) control region. Note that the two individuals (one MDD and one HC) with abnormally high binding potential (BP) in the cerebellar reference region resulted in low values in the DWM region. These two individuals were excluded from all analyses and the MDD and HC did not differ in DWM BP, indicating equivalence in the reference region. Further, no results were changed by including DWM BP as a covariate in analyses.</p>
</caption>
<graphic xlink:href="fpsyg-10-00691-g001"></graphic>
</fig>
<p>Positron emission tomography images were coregistered with MRI images to allow anatomical localization of PET data. Coregistration was accomplished for each subject by alignment of K<sub>1</sub> images with MRI SPGR images using co-registration within SPM2. MRI data were subsequently transformed into standardized coordinates (International Consortium for Brain Mapping; Montreal Neurological Institute) by linear and non-linear warping, and the resulting transformation matrix was applied to parametric PET images.</p>
<p>Although not central to the current study or hypotheses, we specifically addressed the concern that lowered 5-HT<sub>1A</sub> BP<sub>ND</sub> in MDD is a function of differences between HC and MDD in the cerebellar white matter reference region. Without an arterial reference point, we instead added a deep white matter (DWM) ROI within the centrum semiovale for test comparisons between MDD and HC subjects. This technique capitalizes on modeling DWM as a constant in the equation. Without any receptors, DWM would be a constant including noise – the only variable free to vary in the equation is BP within the cerebellar white matter reference region (including noise). There were no significant differences between groups in 5-HT<sub>1A</sub> BP<sub>ND</sub> in the DWM of the centrum semiovale [<italic>t</italic>(41) = 0.55, <italic>p</italic> = 0.59]. The reference region BP was equivalent between groups, increasing confidence that effects reported herein are contingent upon inherent regional differences in BP between MDD and HC groups in the regions specified (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p>
</sec>
<sec>
<title>Candidate Affective and Executive Domains Relevant to MDD</title>
<p>The processing speed with interference resolution includes the trail making test, digit symbol substitution test, stroop color-word test, and response time to targets from the parametric go/no-go test. The parametric go/no-go test was programmed in EPrime 2 completed before the scanning session for practice (<xref ref-type="bibr" rid="B62">Langenecker, 2001</xref>; <xref ref-type="bibr" rid="B64">Langenecker et al., 2007a</xref>,<xref ref-type="bibr" rid="B65">b</xref>,<xref ref-type="bibr" rid="B66">c</xref>, <xref ref-type="bibr" rid="B69">2018a</xref>; <xref ref-type="bibr" rid="B141">Votruba and Langenecker, 2013</xref>). It was also completed during fMRI. There are three levels of difficulty, including a 3 target Go-only condition, and 2 target alternating target Go/No-go condition, and a 2 target alternating target Go/No-go condition. There are 68 “lure” events so that correct and incorrect rejections of lures can be modeled and analyzed separately.</p>
<p>There are also less prominent potential domains/factors, less strongly linked to risk for MDD or BD, comprising Verbal Fluency with Processing Speed, Inhibitory Control, and Conceptual Reasoning and Set Shifting, and tests from these factors have been demonstrated to be dysfunctional in previous studies of MDD (see <xref ref-type="bibr" rid="B71">Langenecker et al., 2009</xref> for a review). Negative Memory Bias (NMB) was calculated as a subtraction of percentage of negative words recognized from the percentage of neutral words recognized from within the Emotion Words task programmed in EPrime 2 (<xref ref-type="bibr" rid="B42">Hsu et al., 2010</xref>). In addition to the Negative Memory Bias, we also used performance accuracy in Emotion Classification of faces as potential Affective Processing domains in MDD that would be linked to abnormal 5-HT<sub>1A</sub> BP<sub>ND</sub> (<xref ref-type="bibr" rid="B63">Langenecker et al., 2005</xref>).</p>
</sec>
<sec>
<title>MRI for Co-registration of PET Images and Collection of fMRI BOLD</title>
<p>One hundred twenty-four high-resolution SPGR axial anatomic images [TE = 5 ms; TR (repetition time) = 24 ms, 45 degree flip angle, NEX (number of excitations) = 2, slice thickness = 1.2 or 1.3 mm, FOV = 24 cm, matrix size = 256 × 256] were performed on each subject with a GE 3T Signa scanner for coregistration of PET images.</p>
<p>The Go/No-go task is a cognitive control task that has been used extensively by our group with fMRI, including in healthy aging, MDD, and bipolar disorder (for review, see <xref ref-type="bibr" rid="B141">Votruba and Langenecker, 2013</xref>). The fMRI task includes event-related models for correctly responded “go” events or Hits, correctly rejected “no-go” events or Rejections, and incorrectly responded “no-go” events, or Commissions, modeled with the hemodynamic response function. The steps for processing the data and model building include slice timing, physiological correction, coregistration, normalization, smoothing with a 5 mm FWHM Gaussian filter, and building individual models using SPM2 as described previously (<xref ref-type="bibr" rid="B66">Langenecker et al., 2007c</xref>). Contrasts were set up to define activation for Hits, Rejections, and Commissions in a fast event-related model. Imaging parameters include a TR of 2000 ms, FOV of 22 cm, with a 3.0 T GE Signa scanner using a standard radio frequency coil and T2<sup>∗</sup>- weighted pulse sequence. The images were collected using a forward-reverse spiral sequence with 29 axial slices of 4 mm.</p>
</sec>
<sec>
<title>Defining Regions of Significant Effect in 5-HT<sub>1A</sub>, and Low and Normal MDD Groups</title>
<p>Differences between groups in 5-HT<sub>1A</sub> BP<sub>ND</sub> will be extracted from regions of significant effects (RSEs). 1st 5-HT<sub>1A</sub> BP<sub>ND</sub> levels will be converted to z scores based upon mean and standard deviation of BP<sub>ND</sub> levels for the HC group for each RSE. Then the z scores will be averaged across all RSEs to create a mean Z Group RSE variable across all post-synaptic 5-HT<sub>1A</sub> regions that differ between groups. Mean Z group RSE will be used as predictor variable in subsequent analyses with performance and fMRI IPs. We will use mean 5-HT<sub>1A</sub> BP<sub>ND</sub> PET results in RSEs to define low and normal 5-HT<sub>1A</sub> BP<sub>ND</sub> MDD groups in relation to HC 5-HT<sub>1A</sub> BP<sub>ND</sub> in the RSEs. These two MDD groups will then be compared to identify regions for fMRI analyses in the imaging contrasts (Commissions, Correct Rejections, Hits) for the Parametric Go/No-go test.</p>
</sec>
<sec>
<title>Genotyping for 5HTTLPR and MAO-A</title>
<p>In addition, for exploratory purposes, the relative impact for <italic>5-HTTLPR</italic> and <italic>MAO-A</italic> genotype were evaluated, genes with a significant biological relationship with 5-HT<sub>1A</sub> BP.</p>
<sec>
<title>5HTTLPR</title>
<p>Genotyping protocols were performed according to <xref ref-type="bibr" rid="B74">Lesch et al. (1996)</xref>. The <italic>5-HTTLPR</italic> assay discriminates between two functional <italic>5-HTT</italic> promoter alleles, visualized as DNA bands of 528 bp and 484 bp (long and short alleles, l and s, respectively). Genotypes were grouped in accordance with <italic>in vitro</italic> data on a reduced transcriptional activity of the dominating s allele that leads to a decrease in central 5-HT turnover (<xref ref-type="bibr" rid="B6">Bennett et al., 2002</xref>). Ten individuals did not have <italic>5-HTTLPR</italic> genotype obtained (6 HC, 4 MDD).</p>
</sec>
<sec>
<title>MAO-A</title>
<p>Genomic DNA was purified from blood using standard methods. The <italic>MAOA</italic> promoter region that contains the upstream VNTR polymorphism (<xref ref-type="bibr" rid="B118">Sabol et al., 1998</xref>) was amplified from 10 ng genomic DNA using the primer sequences: Forward 5 CCCAGGCTGCTCCAGAAACATG-3 and Reverse 5′-GTTCGGGACCTGGGCAGTTGTG-3′. Because of the high GC content in the VNTR region, amplification was performed using Invitrogen’s PlatinumTaq and PCRX. Twenty-three individuals (12 HC, 11 MDD) did not have <italic>MAO-A</italic> genotype obtained.</p>
</sec>
</sec>
<sec>
<title>Statistical Analyses</title>
<p>First, we identified MDD specific regions of low 5-HT<sub>1A</sub> BP<sub>ND</sub> as described in the results section. We compared MDD and HC groups in 5-HT<sub>1A</sub> BP<sub>ND</sub> using a combined threshold of <italic>p</italic> &lt; 0.001 and a cluster minimum of 80mm<sup>3</sup> was used between groups <italic>t</italic>-test in SPM2 (<xref ref-type="table" rid="T2">Table 2</xref> and <xref ref-type="fig" rid="F5">Figure 5</xref>). Mean 5-HT<sub>1A</sub> BP<sub>ND</sub> was extracted for these Regions of Significant Effects (RSEs) and BP<sub>ND</sub> was used in group specific linear regressions in SPSS 22 with behavioral performance measures of affective processing (Negative Memory Bias, Emotion Categorization) and executive functioning (Processing Speed with Interference Resolution, Verbal Fluency with Processing Speed, Inhibitory Control, and Conceptual Reasoning and Set Shifting) factors/scores were evaluated as converging, multimodal candidate IPs using MANOVA in SPSS 22. fMRI BOLD activation differences were also investigated in SPM5 factorial model comparisons of normal and low 5-HT<sub>1A</sub> BP<sub>ND</sub> MDD groups based upon mean 1A BP<sub>ND</sub> (with DWM BP as a covariate of no interest). Relationships between fMRI BOLD signal differences were evaluated subsequently with correlations with RDoC Domains scores in SPSS 22. These domains were also evaluated in exploratory analyses for serotonin-related genetic effects using <italic>5-HTTLPR</italic> and <italic>MAO-A</italic>.</p>
<table-wrap id="T2" position="float">
<label>Table 2</label>
<caption>
<p>Regions of significantly effect, with lower 5-HT<sub>1A</sub> BP<sub>ND</sub> in MDD relative to HC.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Foci</th>
<th align="center" colspan="1" rowspan="1" valign="top">BA</th>
<th align="center" colspan="1" rowspan="1" valign="top">mm<sup>3</sup></th>
<th align="center" colspan="1" rowspan="1" valign="top">x</th>
<th align="center" colspan="1" rowspan="1" valign="top">y</th>
<th align="center" colspan="1" rowspan="1" valign="top">z</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<italic>Z</italic>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<italic>p</italic>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Uncus</td>
<td align="left" colspan="1" rowspan="1" valign="top">20</td>
<td align="left" colspan="1" rowspan="1" valign="top">1344</td>
<td align="left" colspan="1" rowspan="1" valign="top">26</td>
<td align="left" colspan="1" rowspan="1" valign="top">-5</td>
<td align="left" colspan="1" rowspan="1" valign="top">-34</td>
<td align="left" colspan="1" rowspan="1" valign="top">4.38</td>
<td align="left" colspan="1" rowspan="1" valign="top">0.000034</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Hippocampus</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">1536</td>
<td align="left" colspan="1" rowspan="1" valign="top">-25</td>
<td align="left" colspan="1" rowspan="1" valign="top">-13</td>
<td align="left" colspan="1" rowspan="1" valign="top">-20</td>
<td align="left" colspan="1" rowspan="1" valign="top">4.24</td>
<td align="left" colspan="1" rowspan="1" valign="top">0.000053</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Parahippocampal</td>
<td align="left" colspan="1" rowspan="1" valign="top">35</td>
<td align="left" colspan="1" rowspan="1" valign="top">1216</td>
<td align="left" colspan="1" rowspan="1" valign="top">-32</td>
<td align="left" colspan="1" rowspan="1" valign="top">-21</td>
<td align="left" colspan="1" rowspan="1" valign="top">-19</td>
<td align="left" colspan="1" rowspan="1" valign="top">3.96</td>
<td align="left" colspan="1" rowspan="1" valign="top">0.00013</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Superior temporal</td>
<td align="left" colspan="1" rowspan="1" valign="top">38</td>
<td align="left" colspan="1" rowspan="1" valign="top">960</td>
<td align="left" colspan="1" rowspan="1" valign="top">22</td>
<td align="left" colspan="1" rowspan="1" valign="top">10</td>
<td align="left" colspan="1" rowspan="1" valign="top">-37</td>
<td align="left" colspan="1" rowspan="1" valign="top">4.17</td>
<td align="left" colspan="1" rowspan="1" valign="top">0.000068</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fusiform</td>
<td align="left" colspan="1" rowspan="1" valign="top">37</td>
<td align="left" colspan="1" rowspan="1" valign="top">2624</td>
<td align="left" colspan="1" rowspan="1" valign="top">41</td>
<td align="left" colspan="1" rowspan="1" valign="top">-62</td>
<td align="left" colspan="1" rowspan="1" valign="top">-7</td>
<td align="left" colspan="1" rowspan="1" valign="top">3.78</td>
<td align="left" colspan="1" rowspan="1" valign="top">0.00023</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Precuneus</td>
<td align="left" colspan="1" rowspan="1" valign="top">7</td>
<td align="left" colspan="1" rowspan="1" valign="top">832</td>
<td align="left" colspan="1" rowspan="1" valign="top">24</td>
<td align="left" colspan="1" rowspan="1" valign="top">-69</td>
<td align="left" colspan="1" rowspan="1" valign="top">33</td>
<td align="left" colspan="1" rowspan="1" valign="top">3.66</td>
<td align="left" colspan="1" rowspan="1" valign="top">0.00033</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<attrib>
<italic>There were no regions where MDD group had greater BP relative to the HC group.</italic>
</attrib>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec>
<title>Results</title>
<sec>
<title>Defining Regions of Low 5-HT<sub>1A</sub> Binding Potential in the MDD Group</title>
<p>Regions of significant BP differences between HC and MDD groups (HC &gt; MDD) were used to define low 5-HT<sub>1A</sub> BP<sub>ND</sub> MDD regions of significant effect (hereafter RSE). The whole brain analyses in MDD vs HC with 5-HT<sub>1A</sub> BP<sub>ND</sub> indicated six RSEs of lower 5-HT<sub>1A</sub> BP<sub>ND</sub> in the MDD group relative to the HC group. These regions, predominantly temporal, are reported in <xref ref-type="table" rid="T2">Table 2</xref> and <xref ref-type="fig" rid="F5">Figure 5</xref>, defining 10–20% reduction in post-synaptic 5-HT<sub>1A</sub> BP<sub>ND</sub> in MDD across these regions. There were no regions where MDD group had greater BP<sub>ND</sub> relative to the HC group. Half of the MDD group was below the 5th percentile of 5-HT<sub>1A</sub> BP<sub>ND</sub> for the Z normed average of the RSEs relative to the HC group.</p>
</sec>
<sec>
<title>Impact of Low 5HT1a BP<sub>ND</sub> on Executive Functioning and Affective Processing IPs in MDD</title>
<p>We investigated the linear relationship of IPs (e.g., Processing Speed with Interference Resolution, Inhibitory Control, and Negative Memory Bias) with mean rank 5-HT<sub>1A</sub> BP using regression in SPSS 22. Negative Memory Bias accounted for 16.4% (no difference after accounting for age) and Processing Speed with Interference Resolution accounted for 26.3% (35.4% after accounting for age effects) of mean rank BP<sub>ND</sub> in the MDD group (covarying DWM DVR, <italic>p’</italic>s = 0.074, 0.029, respectively, <xref ref-type="fig" rid="F2">Figure 2</xref>). No other IPs were significantly related to mean rank 5-HT<sub>1A</sub> BP<sub>ND</sub> in the MDD group. In the control group, &lt;1% variance in processing speed with interference resolution or negative memory bias was accounted for by mean rank BP<sub>ND</sub>. Negative memory bias and processing speed with interference resolution were non-significantly correlated (<italic>r</italic> = -0.33, <italic>p</italic> = 0.17).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Relationships of Negative Memory Bias (NMB) and Processing Speed with Interference Resolution (PSIR) variables with mean rank 5-HT<sub>1A</sub> BP in the MDD group.</p>
</caption>
<graphic xlink:href="fpsyg-10-00691-g002"></graphic>
</fig>
</sec>
<sec>
<title>Lowered Mean 5-HT<sub>1A</sub> BP in Relation to fMRI BOLD Responses to Hits, Rejections, and Commissions Within the MDD Group</title>
<p>It was expected that abnormalities in executive functioning domains based upon mean 5-HT<sub>1A</sub> BP<sub>ND</sub> would also be related to BOLD fMRI differences. As this has not been evaluated in published studies, there was no clear expectation of hyper or hypo (our hypothesis) activation during the Cognitive Control task for low vs normal 5-HT<sub>1A</sub> BP groups. These contrasts in SPM5 included in separate models for BOLD responses during Hits, Correct Rejections, and Commissions. Rejections and Commissions are used to calculate Inhibitory Control, which would be expected to be related to 5-HT<sub>1A</sub> BP<sub>ND</sub> based upon relationships illustrated in <xref ref-type="fig" rid="F3">Figure 3</xref>. Processing speed with interference resolution includes response speed to Hits and Conceptual Reasoning with Set Shifting includes Hit accuracy, suggesting that these Hit events should also be related to 5-HT<sub>1A</sub> BP<sub>ND</sub>. There were some individuals without fMRI scans, some with abnormal DVR in the cerebellum (see section “Materials and Methods”), and some with low IQ, leaving, 17 MDD subjects available for fMRI analyses (divided into normal and low, in a model with 19 HCs). Whole brain analyses were conducted using combined height and extent thresholds with 3dClustSim (<italic>p</italic> &lt; 0.005, <italic>k</italic> &gt; 55, 1000 Monte Carlo simulations, <italic>p</italic> &lt; 0.05 whole brain adjusted).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Figure illustrates significant BOLD activation relationships with 5HT-1a BP in the MDD group. There was greater BOLD activation with normal 5-HT<sub>1A</sub> BP MDD in the Parametric Go/No-go test. This is shown for correct Hits (Panel <bold>C,D</bold>, cyan), for Commissions (Panel <bold>B</bold>, red), Correct Rejections (Panels <bold>C,E</bold>, yellow). There were also a few areas of greater activation for correct Hits with low 5-HT<sub>1A</sub> BP in the MDD group (Panels <bold>A,D</bold>, green).</p>
</caption>
<graphic xlink:href="fpsyg-10-00691-g003"></graphic>
</fig>
<p>Within the MDD sample, there was a general pattern of greater activation with increasing mean 5-HT<sub>1A</sub> BP<sub>ND</sub>. For Correct Rejections (yellow, <xref ref-type="fig" rid="F3">Figure 3</xref>, Panels C, E), this was observed in dorsal anterior cingulate, postcentral gyrus, left posterior insula, and mid cingulate gyrus RSEs. There was increasing activation in rostral anterior cingulate, left inferior frontal gyrus, bilateral dorsal medial thalamus, and pulvinar RSEs with greater mean 5-HT<sub>1A</sub> BP<sub>ND</sub> in relation to Commissions. There was greater activation for Hits in a left posterior insula RSE related to mean 5-HT<sub>1A</sub> BP<sub>ND</sub> (cyan, <xref ref-type="fig" rid="F3">Figure 3</xref>, Panel C). The exception to this general pattern of increased activation with increasing mean 5-HT<sub>1A</sub> BP in MDD was observed for Hits in bilateral superior parietal lobule and right anterior inferior frontal gyrus, where there was decreasing activation as mean 5-HT<sub>1A</sub> BP<sub>ND</sub> increased (green, <xref ref-type="fig" rid="F3">Figure 3</xref>, Panels A and D).</p>
<p>We further investigated dimensional, linear links between these multimodal IPs using pairwise correlations between the mean rank 5-HT<sub>1A</sub> BP<sub>ND</sub>, mean rank for the combined fMRI BOLD RSEs (by condition), and behavioral performance parameters. These fMRI BOLD RSE clusters were combined by condition and group difference for purposes of data reduction, with the resulting mean Z BOLD RSE scores highly correlated with all individual clusters (<italic>r</italic>’s &gt; 0.59 for Commission clusters, <italic>r</italic>’s &gt; 0.68 for Correct Rejection clusters, <italic>r</italic>’s &gt; 0.78 for Hits clusters, <italic>p</italic>’s &lt; 0.001). As illustrated in <xref ref-type="fig" rid="F4">Figure 4</xref>, the mean Z fMRI BOLD RSEs were significantly correlated with mean rank 5-HT<sub>1A</sub> BP for Hit BOLD RSE Normal &gt; Low (<italic>r</italic> = 0.73, <italic>p</italic> &lt; 0.001, <xref ref-type="fig" rid="F4">Figure 4</xref>, Panel A), Hits mean Z BOLD RSEs Low &gt; Normal (<italic>r</italic> = -0.80, <italic>p</italic> = 0.0001, Panel B), Commissions mean Z BOLD RSEs Normal &gt; Low (<italic>r</italic> = 0.87, <italic>p</italic> = 0.0001, Panel E), and Rejections mean Z BOLD RSEs Normal &gt; Low (<italic>r</italic> = 0.77, <italic>p</italic> = 0.0001, Panel C). PSIR Z score was positively correlated with fMRI BOLD Hit RSE (Normal &gt; Low, <italic>r</italic> = 0.54, <italic>p</italic> = 0.02) and fMRI BOLD Commission mean Z RSEs (Normal &gt; Low, <italic>r</italic> = 0.53, <italic>p</italic> = 0.03, Panel F). Negative Memory Bias Z was significantly positively correlated with fMRI BOLD Hit mean Z RSEs (Low &gt; Normal, <italic>r</italic> = 0.50, <italic>p</italic> = 0.04) and negatively with fMRI BOLD Rejections mean Z RSEs (Normal &gt; Low, <italic>r</italic> = -0.59, <italic>p</italic> = 0.01, Panel D). Information from 19 HCs with all modalities of measurement included – are added to these scatterplots (<xref ref-type="fig" rid="F4">Figure 4</xref>) for comparison. The scatterplots indicate individual level differences in fMRI for Cognitive Control that relate to 5-HT<sub>1A</sub> BP<sub>ND</sub> and PSIR.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Illustration of linear relationships by group for 5-HT<sub>1A</sub> BP, fMRI BOLD signal, and neuropsychological performance measures (MDD in black, HC in gray, dashed line for both). Panel <bold>A</bold> shows the relationship between BOLD activation or Hits in left posterior insula with mean 5-HT<sub>1A</sub> BP rank. Panel <bold>B</bold> illustrates the relationship between mean BOLD signal RSEs for correct Hits that are greater in normal relative to lower 5-HT<sub>1A</sub> BP in MDD with mean 5-HT<sub>1A</sub> BP rank. Panel <bold>C</bold> depicts the relationship between mean BOLD for correct rejections and mean 5-HT<sub>1A</sub> BP rank. The relationship between mean BOLD for correct rejections and NMB in shown in Panel <bold>D</bold>. Panel <bold>E</bold> illustrates the mean BOLD for commission errors with mean 5-HT<sub>1A</sub> BP rank. The relationship between mean BOLD for commission errors and processing speed with interference resolution is shown in Panel <bold>F</bold>.</p>
</caption>
<graphic xlink:href="fpsyg-10-00691-g004"></graphic>
</fig>
</sec>
<sec>
<title>Exploratory Analyses of <italic>5-HTTLPR</italic> and <italic>MAO-A</italic> Effects in Executive Functioning and Affective Processing IPs</title>
<p>Next, we expected that the low functioning forms of either the <italic>MAO-A</italic> and <italic>5HTTLPR</italic> genotypes would be associated with poorer performance irrespective of group for candidate genes in exploratory analyses. Given the small sample size, and the relatively weak link between Cognitive/Affective IPs and functional polymorphisms that might impact 5-HT<sub>1A</sub>, the probability of type II error is high. The MANCOVA for <italic>5-HTTLPR</italic> (diagnosis as covariate) was significant for Conceptual Reasoning and Set Shifting [<italic>F</italic>(1,29) = 4.29, <italic>p</italic> = 0.047, <italic>E</italic><sup>2</sup> = 0.13] and Processing Speed with Interference Resolution [<italic>F</italic>(1,29) = 5.93, <italic>p</italic> = 0.02, <italic>E</italic><sup>2</sup> = 0.17], with poorer performance in <italic>s</italic> allele carriers irrespective of group status. For definition of high and low functioning <italic>MAO-A</italic> genes, the intermediate genotype group of women was placed into the low functioning allele group based upon prior results (<xref ref-type="bibr" rid="B5">Austin et al., 1999</xref>) There was a significant effect for genotype on Conceptual Reasoning and Set Shifting [<italic>F</italic>(1,26) = 5.73, <italic>p</italic> = 0.02, <italic>E</italic><sup>2</sup> =0 .18] and a trend for Emotion Categorization [<italic>F</italic>(1,26) = 3.35, <italic>p</italic> = 0.08, <italic>E</italic><sup>2</sup> = 0.11]. Those with low function alleles for <italic>MAO-A</italic> performed better on Conceptual Reasoning and Set Shifting and marginally worse on Emotion Categorization.</p>
</sec>
<sec>
<title>5-HT<sub>1A</sub> BP<sub>ND</sub> Links to <italic>5-HTTLPR</italic> Genotype and Relationship With PSIR</title>
<p>Next, we evaluated specifically the effect of <italic>5-HTLPPR</italic> genotype on 5-HT<sub>1A</sub> BP<sub>ND</sub> reductions, covarying for disease group. Group results based upon disease (from <xref ref-type="table" rid="T2">Table 2</xref>) and genotype are displayed in <xref ref-type="fig" rid="F5">Figure 5</xref> (Panels A and B). Those with the <italic>5-HTTLPR s</italic> allele, irrespective of disease status, exhibited lower 5-HT<sub>1A</sub> BP<sub>ND</sub> in fronto-temporal regions, overlapping with temporal regions that were lower in those with MDD. There were additional frontal regions of lower 5-HT<sub>1A</sub> BP<sub>ND</sub> in <italic>s</italic> allele carriers irrespective of diagnosis.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Areas of greater 5-HT<sub>1A</sub> BP in HC relative to MDD (blue) and in <italic>l</italic> homozygotes for <italic>5-HTTLPR</italic> relative to <italic>s/s or l/s</italic> (red) in Panels <bold>A,B</bold>. Note that the blue clusters are the same as those listed in <xref ref-type="table" rid="T2">Table 2</xref>, which were used to define the regions of significant effect that defined mean rank BP regressors. They are included for comparison with the <italic>5-HTTLPR</italic> analysis here to show the similarities in location and direction. Panel <bold>C</bold> depicts the actual and predicted PSIR values. The predictions are based upon mean 5-HT<sub>1A</sub> BP values from the regions of significant effect (RSEs) in the <italic>5-HTTLPR</italic> analysis.</p>
</caption>
<graphic xlink:href="fpsyg-10-00691-g005"></graphic>
</fig>
<p>Mean rank order BP based upon <italic>5-HTTLPR</italic> was averaged across all 16 RSEs of greater BP in <italic>l/l</italic> homozygotes relative to the <italic>s</italic> allele carriers. Regression was used to predict Processing Speed with Interference Resolution based upon <italic>5-HTTLPR</italic> and also using mean rank BP from the <italic>5-HTTLPR</italic> RSEs. Fifty-two percent of Processing Speed with Interference Resolution was explained by 5-HT<sub>1A</sub> BP<sub>ND</sub> regions with significantly low BP extracted in those with an <italic>s</italic> allele (covarying age and DWM DVR, <italic>B</italic> = 0.79, <italic>p</italic> = 0.001, <xref ref-type="fig" rid="F5">Figure 5</xref>, Panel C). 5-HT<sub>1A</sub> RSEs defined by MDD vs control and by <italic>5-HTTLPR</italic> were highly correlated (<italic>r</italic> = 0.88, <italic>p</italic> &lt; 0.001) in 5-HT<sub>1A</sub> BP<sub>ND</sub>. MDD and <italic>5-HTTLPR s</italic> allele were retained as independent variables in this analysis. No other regression models reached significance when using mean rank BP from the <italic>5-HTTLPR</italic> RSEs to predict Negative Memory Bias, Emotion Categorization, Inhibitory Control, or Conceptual Reasoning with Set Shifting.</p>
</sec>
</sec>
<sec>
<title>Discussion</title>
<p>The present study is the first to link abnormal 5-HT<sub>1A</sub> BP<sub>ND</sub> measures in unmedicated, symptomatic patients with MDD to objective performance and imaging markers of illness, in this case interference resolution, a component of Cognitive Control. The separation of interference resolution performance by 5-HT<sub>1A</sub> levels is marked, with a medium-large effect size. The abnormal 5-HT<sub>1A</sub> BP<sub>ND</sub> is also related to fMRI BOLD hypoactivation changes in a Cognitive Control domain during Inhibitory Control, the Parametric Go/No-Go Test. The impact of <italic>5-HTTLPR</italic> genotype upon interference resolution and 5-HT<sub>1A</sub> is modest and significant. The results follow previous studies showing links between 5-HT<sub>1A</sub> BP<sub>ND</sub> values with clinical factors such as anxiety symptoms, treatment outcome, genetics, and sex (<xref ref-type="bibr" rid="B8">Bhagwagar et al., 2004</xref>; <xref ref-type="bibr" rid="B24">Drevets et al., 2007</xref>; <xref ref-type="bibr" rid="B39">Hirvonen et al., 2008</xref>; <xref ref-type="bibr" rid="B91">Miller et al., 2008</xref>; <xref ref-type="bibr" rid="B101">Parsey et al., 2010</xref>). There is also evidence that lower 5-HT<sub>1A</sub> levels are present when there are increased depression symptoms in the context of epilepsy, Parkinson disease and in chronic stress without depression (<xref ref-type="bibr" rid="B49">Jovanovic et al., 2008</xref>). Using objective, but simpler, performance measures to identify subjects with a higher probability of abnormal 5-HT<sub>1A</sub> BP<sub>ND</sub> could have substantial benefits for clinical, genetic and research studies. The executive functioning measures used to derive the processing speed with interference resolution variables are inexpensive to administer and are easily employed in subject recruitment (even clinical) settings (<xref ref-type="bibr" rid="B65">Langenecker et al., 2007b</xref>; <xref ref-type="bibr" rid="B22">Dawson et al., 2017</xref>). These measures could be used to select individuals for treatments or research protocols that specifically target 5-HT<sub>1A</sub> receptor functioning and for subtype-specific pharmacotherapy treatment trials. Analogs of these performance measures are already present in animal models to further aid in strategies for better understanding the neurobiology and genetics of depression and for new treatment development.</p>
<p>In the data presented it was striking that Cognitive Control, and not Negative Memory Bias (inverted effect) or Emotion Categorization, was related to lower 5-HT<sub>1A</sub> BP<sub>ND</sub> in MDD. Indeed, recent studies have demonstrated that executive functioning measures, an umbrella domain term that includes Cognitive Control, are perhaps most critical in understanding increased risk for MDD, and are observed in the remitted state, and in family relatives of those with mood disorders (<xref ref-type="bibr" rid="B16">Clark et al., 2005</xref>; <xref ref-type="bibr" rid="B9">Bora et al., 2009</xref>; <xref ref-type="bibr" rid="B103">Peters et al., 2017</xref>). A recent review illustrated how executive dysfunction for those with MDD is substantial and fairly consistent across well-powered studies (<xref ref-type="bibr" rid="B112">Rogers et al., 2004</xref>). Some existing literature, although mainly with small N studies, suggest that executive functioning is also a good predictor of treatment response and functioning in MDD (<xref ref-type="bibr" rid="B52">Kampf-Sherf et al., 2004</xref>; <xref ref-type="bibr" rid="B135">Taylor et al., 2006</xref>; <xref ref-type="bibr" rid="B47">Jaeger et al., 2007</xref>; <xref ref-type="bibr" rid="B22">Dawson et al., 2017</xref>). Executive functioning also can be used to predict recurrence (<xref ref-type="bibr" rid="B69">Langenecker et al., 2018a</xref>) and workplace disability (<xref ref-type="bibr" rid="B73">Lee et al., 2018</xref>).</p>
<p>A recent review of 5-HT<sub>1A</sub> receptor studies suggested that there is a weak relationship between 5-HT<sub>1A</sub> and cognitive function (<xref ref-type="bibr" rid="B10">Borg, 2008</xref>). One of four studies in healthy controls have illustrated a relationship between 5-HT<sub>1A</sub> BP<sub>ND</sub> and cognitive performance (<xref ref-type="bibr" rid="B147">Yasuno, 2004</xref>). A pilot study in those with Alzheimer’s disease, mild cognitive impairment (MCI), or neither suggested a relationship of decreased 5-HT<sub>1A</sub> BP<sub>ND</sub> with poorer MMSE in the entire sample, and with learning and memory in the healthy control and MCI participants (<xref ref-type="bibr" rid="B56">Kepe et al., 2006</xref>). Another study suggests that gray matter thickness in key limbic regions is positively associated with 5-HT<sub>1A</sub> (<xref ref-type="bibr" rid="B60">Kraus et al., 2012</xref>). A similar study shows these associations in fronto-limbic regions (<xref ref-type="bibr" rid="B150">Zanderigo et al., 2018</xref>). In our control sample we replicate the pattern of non-significant relationships of 5-HT<sub>1A</sub> BP<sub>ND</sub> to cognitive and affective measures. However, in MDD, we demonstrate a significant positive relationship of 5-HT<sub>1A</sub> with Negative Memory Bias and Inhibitory Control, and a significant negative relationship of 5-HT<sub>1A</sub> with Processing Speed with Interference Resolution.</p>
<p>fMRI BOLD signal changes for correct rejections and errors of commission resulted in hypoactivation in critical regulatory and inhibitory regions for those with lower 5-HT<sub>1A</sub> BP<sub>ND</sub>. These low BOLD signals were related to Negative Memory Bias and Processing Speed with Interference Resolution. Notably, those MDD with lower 5-HT<sub>1A</sub> BP<sub>ND</sub> levels show increasing difficulties with poorer set-shifting and processing speed. In contrast and with an intriguing result, MDD subjects with higher/normative 5-HT<sub>1A</sub> BP<sub>ND</sub> levels exhibited significant Negative Memory Bias and increased activation in regulatory regions during successful rejection. As a result, increased need for recruitment in the mid-dorsal and rostral anterior cingulate for successful rejection may reflect poorer Inhibitory Control in those without lower 5-HT<sub>1A</sub> BP<sub>ND</sub> levels. This observation is confirmed by performance above normal levels in Inhibitory Control as 5-HT<sub>1A</sub> BP<sub>ND</sub> levels decreased. Those with higher/normative5-HT<sub>1A</sub> BP<sub>ND</sub> 5-HT<sub>1A</sub> BP<sub>ND</sub> levels tended to have worse Negative Memory Bias, Inhibitory Control, and increased BOLD recruitment for successful rejection of prepotent stimuli. Although the sample is quite small, these results reaffirm with other work that there likely many circuits, neurotransmitters, and behaviors associated with subtypes of MDD that are heretofore unclear (<xref ref-type="bibr" rid="B142">Webb et al., 2016</xref>; <xref ref-type="bibr" rid="B57">Kling et al., 2018</xref>).</p>
<p>Further, <italic>5-HTTLPR</italic> appears to be related to both 5-HT<sub>1A</sub> BP<sub>ND</sub> levels, and executive functioning performance, irrespective of illness. Notably, samples of this small size often suffer from difficulty with replication and should be interpreted very cautiously. There are some clues, however, that interference resolution might explain the inconsistent findings in emotion processing studies of <italic>5-HTTLPR</italic> from other studies as well. For example, affective processing and executive regulation can be in dynamic opposition to one another in some contexts, or in the case of psychiatric illness, there may be excessive responses in the former <italic>and</italic> weaker control in the latter (<xref ref-type="bibr" rid="B104">Phillips et al., 2003</xref>; <xref ref-type="bibr" rid="B52">Kampf-Sherf et al., 2004</xref>; <xref ref-type="bibr" rid="B66">Langenecker et al., 2007c</xref>, <xref ref-type="bibr" rid="B68">2014</xref>). Presence of the low functioning alleles of <italic>5-HTTLPR</italic> may reflect a relatively weaker executive functioning system, resulting in a stronger environmental dependence in the development of and execution of emotion regulation (<xref ref-type="bibr" rid="B46">Jacobs et al., 2006</xref>; <xref ref-type="bibr" rid="B21">Dannlowski et al., 2008</xref>; <xref ref-type="bibr" rid="B79">Lohoff et al., 2014</xref>; <xref ref-type="bibr" rid="B106">Piel et al., 2018</xref>). In non-stressful environments, this weakness is less likely to result in problematic outcomes, but could still result in excessive responses to negative emotional stimuli (<xref ref-type="bibr" rid="B124">Sen et al., 2004</xref>; <xref ref-type="bibr" rid="B132">Surguladze et al., 2008</xref>). This pattern of diminished regulation skill in those carrying the short allele may be exaggerated in MDD (<xref ref-type="bibr" rid="B21">Dannlowski et al., 2008</xref>). In high demand, high stress, negative environments, there may be greater difficulty in regulating negative emotional responses, and greater difficulty in shifting from one emotional state to another for those with low functioning <italic>5-HTTLPR</italic> alleles (<xref ref-type="bibr" rid="B46">Jacobs et al., 2006</xref>; <xref ref-type="bibr" rid="B95">Neumeister et al., 2006</xref>; <xref ref-type="bibr" rid="B106">Piel et al., 2018</xref>). The lack of regulation or emotional flexibility to environmental demands could then perpetuate depressive symptoms.</p>
<p>Use of screening tools like PSIR measures, with knowledge of convergent results with the 5-HT<sub>1A</sub> BP<sub>ND</sub> levels may be one dimensional way of increasing the homogeneity in MDD samples. Such increased homogeneity could lead to more targeted, precision medicine trials. For example, preselecting individuals based upon poor Cognitive Control could lead to a larger percentage with low 5-HT<sub>1A</sub> BP<sub>ND</sub>, facilitating identification of related biomarkers for treatment. As we already know that weaker CC is a predictor of poor treatment response, greater likelihood of recurrence, these individuals might benefit from different treatment algorithms [e.g., TMS trials (<xref ref-type="bibr" rid="B52">Kampf-Sherf et al., 2004</xref>; <xref ref-type="bibr" rid="B48">Januel et al., 2006</xref>; <xref ref-type="bibr" rid="B126">Siegle et al., 2006</xref>; <xref ref-type="bibr" rid="B66">Langenecker et al., 2007c</xref>,<xref ref-type="bibr" rid="B67">d</xref>, <xref ref-type="bibr" rid="B69">2018a</xref>,<xref ref-type="bibr" rid="B70">b</xref>; <xref ref-type="bibr" rid="B75">Levkovitz et al., 2009</xref>; <xref ref-type="bibr" rid="B25">Drysdale et al., 2016</xref>; <xref ref-type="bibr" rid="B18">Crane et al., 2017</xref>; <xref ref-type="bibr" rid="B22">Dawson et al., 2017</xref>; <xref ref-type="bibr" rid="B94">Natania et al., 2018</xref>)].</p>
<p>It is also notable that Emotion Categorization accuracy, although related at a trend level to MAO-A genotype, was not related to 5-HT<sub>1A</sub> BP<sub>ND</sub> levels or <italic>5-HTTLPR</italic>. More surprisingly, higher mean rank BP was associated with <italic>greater</italic> Negative Memory Bias in MDD. Those with lower 5-HT<sub>1A</sub> BP<sub>ND</sub> exhibited no evidence of a Negative Memory Bias, suggesting that using mean rank BP to illustrate dimensional functioning in MDD could be defined in part by the segregation of Affective and Executive Domains. In reality, though, risk for MDD is likely defined by affective dysfunction, executive dysfunction, <italic>or</italic> dysfunction in both systems, and it is unlikely to be so clearly illustrated based upon results from one ligand. Several recent studies reported mixed results in links between serotonin genes and emotion reactivity (<xref ref-type="bibr" rid="B58">Kranz et al., 2018</xref>; <xref ref-type="bibr" rid="B106">Piel et al., 2018</xref>).</p>
<p>The main limitation of the study is the sample size. We were able to obtain a relatively large sample for a multimodal study, and we were also able to find strong biological links between different measurement modalities. Samples of this size only reliably find large and very large effect sizes. We did obtain robust results consistent with our hypotheses. Another potential limitation of the present study relates to the broader difficulty within the field to agree upon the best reference strategy for calculating 5-HT<sub>1A</sub> BP<sub>ND</sub>. Although we have shown equivalence in our reference region between groups. There are challenges to the reference region approach that appear to be surmountable by excluding gray matter and vermis, such as in this work (<xref ref-type="bibr" rid="B101">Parsey et al., 2010</xref>), and verifying equivalence of the reference region, as we have done. Animal models, especially those of 5-HT<sub>1A</sub> knockout mice, suggest that there may be lower 5-HT<sub>1A</sub> availability in MDD and similar states, resulting in decreased serotonergic regulation. Likewise, postmortem data also suggests decreased 5-HT<sub>1A</sub> mRNA in MDD. These findings are contrasted with others suggesting that higher 5-HT<sub>1A</sub> in mice can mimic aspects of autism and not anxiety/depression. We contend that the present results strengthen evidence that lower 5-HT<sub>1A</sub> BP<sub>ND</sub> is a viable IP in MDD. This is in part upon the clear lack of BP difference in a deep white matter region, the presence of a behavioral performance correlate, links to fMRI BOLD, and link to a genetic marker <italic>5-HTTLPR</italic>. At the very least, the fact that 5-HT<sub>1A</sub> BP<sub>ND</sub> is altered in some individuals with MDD is clear. Until the discrepant reference region/correction methods can be resolved, directionality is still contested. Individual studies will have to demonstrate equivalence of reference ranges/structures. Furthermore, newer radioligands such as (<xref ref-type="bibr" rid="B26">Elton et al., 2014</xref>) MPFF might have more sensitive and stable properties for investigation of 5-HT<sub>1A</sub> BP<sub>ND</sub> with MDD subjects absent these reference region concerns (<xref ref-type="bibr" rid="B82">Lothe et al., 2012</xref>).</p>
<p>In addition, fMRI is expensive and requires extensive equipment for set-up and analysis. A lower cost alternative to measure hemoglobin changes during task may be functional near-infrared spectroscopy (fNIRS) (<xref ref-type="bibr" rid="B40">Ho et al., 2016</xref>). As a number of the imaging regions identified here were cortical, it is possible that fNIRS could be used less expensively and with a broader range of patients to understand the relationship of hemodynamic changes to lowered 5-HT<sub>1A</sub> function and cognitive control (<xref ref-type="bibr" rid="B88">McKendrick et al., 2015</xref>). Finally, neuropsychological testing, fMRI and PET were typically collected on separate days and locations. The anatomical cross-localization could be off in such instances, and the measurements could be weakened by day-session specific parameters (<xref ref-type="bibr" rid="B123">Selvaraj et al., 2017</xref>; <xref ref-type="bibr" rid="B33">Hamilton et al., 2018</xref>). As the relationships were quite robust, there may have been additional links that were missed.</p>
<p>5-HT<sub>1A</sub> function has a number of associations with other chronic diseases that are often comorbid with MDD, including coronary artery disease and obesity (<xref ref-type="bibr" rid="B139">Vickers and Dourish, 2004</xref>; <xref ref-type="bibr" rid="B110">Ramage and Villalon, 2008</xref>; <xref ref-type="bibr" rid="B109">Quek et al., 2017</xref>; <xref ref-type="bibr" rid="B41">Ho et al., 2018</xref>), and changes in 5-HT<sub>1A</sub> function are coassociated with changes in pro-inflammatory cytokines including interleukin-1 beta (IL-1β), IL-17, and tumor necrosis factor – alpha (TNF-α) (<xref ref-type="bibr" rid="B4">Aune et al., 1993</xref>; <xref ref-type="bibr" rid="B83">Lu et al., 2017</xref>; <xref ref-type="bibr" rid="B96">Ng et al., 2018</xref>). These studies suggest that 5-HT<sub>1A</sub> shares functions that are related to, but extend beyond the phenotype of MDD, which in light of the present study, further confirms a need for homogeneous subsets that can be used to explore specific biological pathways for illness and recovery.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>In conclusion, the present study offers promising new evidence that biomarkers for MDD can be found and objectively measured. The heterogeneity of MDD has been problematic in pursuing these biomarkers, and identification of subtypes of MDD may, in the end, prove to be the most fruitful in linking biomarkers, to phenotypes, to genetic risks, and ultimately to personalized medicine. The phenotypic heterogeneity of MDD, combined with prior attempts at a “one size fits all” biomarker approach to MDD has been one limiting factor in this complex illness. Future work can capitalize upon the relationship between 5-HT<sub>1A</sub> BP<sub>ND</sub> abnormalities and executive functioning in MDD. These links could also be pursued more broadly in other psychiatric conditions within the RDoC initiative, as executive functioning disruption is not specific to MDD.</p>
</sec>
<sec>
<title>Ethics Statement</title>
<p>The work was approved by the University of Michigan IRB. Written informed consent was obtained from all participants.</p>
</sec>
<sec>
<title>Author Contributions</title>
<p>SL designed the study, analyzed the data, and wrote and edited the manuscript. BM performed the PET and cognitive analyses, and wrote and edited the manuscript. PE, SK, and TL performed the PET analysis, and wrote and edited the manuscript. SS performed the genetics analysis, and wrote and edited the manuscript. KE performed the analysis, and wrote and edited the manuscript. MH and SR wrote and edited the manuscript. DH performed the fMRI and PET analyses, and wrote and edited the manuscript. RK designed PET, and edited the manuscript. SW and HA designed the study and edited the manuscript. DG performed the genetics, analysis and edited the manuscript. MB designed the study, performed the genetics analysis, and edited the manuscript. J-KZ designed the study, and wrote and edited the manuscript.</p>
</sec>
<sec>
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> NIMH grants P01 MH42251 (J-KZ, Elizabeth A. Young, HA), K23 MH074459 (SL), and the National Alliance for Research on Schizophrenia and Depression (NARSAD, SL, J-KZ). SL was supported by RDoC grant MH101487. Also supported by the General Clinical Research Center at the University of Michigan (NIH grant RR00042), now MICH-R CTSA (UL1RR024986).</p>
</fn>
</fn-group>
<ack>
<p>We thank Virginia Murphy-Weinberg, RN, MS, Emily M. Briceño, Leslie M. Guidotti-Breting, Allison M. Kade and the technologists of the PET Center and fMRI Laboratory at the University of Michigan for their assistance in the performance of the studies. We thank Colin Hodgkinson, NIAAA, NIH for assistance in genetic analyses.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akil</surname><given-names>H.</given-names></name></person-group> (<year>2005</year>). <article-title>Stressed and depressed.</article-title>
<source/><italic>Nature Nat. Medicine Med.</italic>
<volume>11</volume>
<fpage>116</fpage>–<lpage>118</lpage>. <pub-id pub-id-type="doi">10.1038/nm0205-116</pub-id>
<pub-id pub-id-type="pmid">15692589</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albert</surname><given-names>P. R.</given-names></name><name><surname>Lemonde</surname><given-names>S.</given-names></name></person-group> (<year>2004</year>). <article-title>5-HT<sub>1A</sub> receptors, gene repression, and depression: guilt by association.</article-title>
<source/><italic>Neuroscientist</italic>
<volume>10</volume>
<fpage>575</fpage>–<lpage>593</lpage>. <pub-id pub-id-type="doi">10.1177/1073858404267382</pub-id>
<pub-id pub-id-type="pmid">15534042</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="book"><collab>American Psychiatric Association.</collab> (<year>1994</year>). <source/><italic>Diagnostic and Statistical Manual of Mental Disorders</italic>
<edition>4th Edn.</edition>
<publisher-loc>Washington, DC</publisher-loc>: <publisher-name>American Psychiatric Association</publisher-name>.</mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aune</surname><given-names>T. M.</given-names></name><name><surname>McGrath</surname><given-names>K. M.</given-names></name><name><surname>Sarr</surname><given-names>T.</given-names></name><name><surname>Bombara</surname><given-names>M. P.</given-names></name><name><surname>Kelley</surname><given-names>K. A.</given-names></name></person-group> (<year>1993</year>). <article-title>Expression of 5HT1a receptors on activated human T cells. Regulation of cyclic AMP levels and T cell proliferation by 5-hydroxytryptamine.</article-title>
<source/><italic>J. Immunol.</italic>
<volume>151</volume>
<fpage>1175</fpage>–<lpage>1183</lpage>. <pub-id pub-id-type="pmid">8393041</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Austin</surname><given-names>M. P.</given-names></name><name><surname>Wilhelm</surname><given-names>K.</given-names></name><name><surname>Parker</surname><given-names>G.</given-names></name><name><surname>Hickie</surname><given-names>I.</given-names></name><name><surname>Brodaty</surname><given-names>H.</given-names></name><name><surname>Chan</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>1999</year>). <article-title>Cognitive function in depression : a distinct pattern of frontal impairment in melancholia?</article-title>
<source/><italic>Psychological Psychol. Medicine Med.</italic>
<volume>29</volume>
<fpage>73</fpage>–<lpage>85</lpage>. <pub-id pub-id-type="pmid">10077295</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>A. J.</given-names></name><name><surname>Lesch</surname><given-names>K. P.</given-names></name><name><surname>Heils</surname><given-names>A.</given-names></name><name><surname>Long</surname><given-names>J. C.</given-names></name><name><surname>Lorenz</surname><given-names>J. G.</given-names></name><name><surname>Shoaf</surname><given-names>S. E.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>Early experience and serotonin transporter gene variation interact to influence primate CNS function.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>7</volume>
<fpage>118</fpage>–<lpage>122</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4000949</pub-id>
<pub-id pub-id-type="pmid">11803458</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bert</surname><given-names>B.</given-names></name><name><surname>Fink</surname><given-names>H.</given-names></name><name><surname>Rothe</surname><given-names>J.</given-names></name><name><surname>Walstab</surname><given-names>J.</given-names></name><name><surname>Bonisch</surname><given-names>H.</given-names></name></person-group> (<year>2008</year>). <article-title>Learning and memory in 5-HT(1A)-receptor mutant mice.</article-title>
<source/><italic>Behav. Brain Res.</italic>
<volume>195</volume>
<fpage>78</fpage>–<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2008.02.028</pub-id>
<pub-id pub-id-type="pmid">18396339</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhagwagar</surname><given-names>Z.</given-names></name><name><surname>Rabiner</surname><given-names>E. A.</given-names></name><name><surname>Sargent</surname><given-names>P. A.</given-names></name><name><surname>Grasby</surname><given-names>P. M.</given-names></name><name><surname>Cowen</surname><given-names>P. J.</given-names></name></person-group> (<year>2004</year>). <article-title>Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>9</volume>
<fpage>386</fpage>–<lpage>392</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4001401</pub-id>
<pub-id pub-id-type="pmid">15042104</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bora</surname><given-names>E.</given-names></name><name><surname>Yucel</surname><given-names>M.</given-names></name><name><surname>Pantelis</surname><given-names>C.</given-names></name></person-group> (<year>2009</year>). <article-title>Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives.</article-title>
<source/><italic>J. Affect. Disord.</italic>
<volume>113</volume>
<fpage>1</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/j.jad.2008.06.009</pub-id>
<pub-id pub-id-type="pmid">18684514</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borg</surname><given-names>J.</given-names></name></person-group> (<year>2008</year>). <article-title>Molecular imaging of the 5-HT<sub>1A</sub> receptor in relation to human cognition.</article-title>
<source/><italic>Behav. Brain Res.</italic>
<volume>195</volume>
<fpage>103</fpage>–<lpage>111</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2008.06.011</pub-id>
<pub-id pub-id-type="pmid">18606193</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bradley</surname><given-names>B. P.</given-names></name><name><surname>Mogg</surname><given-names>K.</given-names></name><name><surname>Millar</surname><given-names>N.</given-names></name></person-group> (<year>1996</year>). <article-title>Implicit memory bias in clinical and non-clinical depression.</article-title>
<source/><italic>Behav. Res. Ther.</italic>
<volume>34</volume>
<fpage>865</fpage>–<lpage>879</lpage>. <pub-id pub-id-type="doi">10.1016/S0005-7967(96)00074-5</pub-id><pub-id pub-id-type="pmid">8990538</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burmeister</surname><given-names>M.</given-names></name><name><surname>McInnis</surname><given-names>M. G.</given-names></name><name><surname>Zollner</surname><given-names>S.</given-names></name></person-group> (<year>2008</year>). <article-title>Psychiatric genetics: progress amid controversy.</article-title>
<source/><italic>Nat. Rev. Genet.</italic>
<volume>9</volume>
<fpage>527</fpage>–<lpage>540</lpage>. <pub-id pub-id-type="doi">10.1038/nrg2381</pub-id>
<pub-id pub-id-type="pmid">18560438</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burt</surname><given-names>D. B.</given-names></name><name><surname>Zembar</surname><given-names>M. J.</given-names></name><name><surname>Niederehe</surname><given-names>G.</given-names></name></person-group> (<year>1995</year>). <article-title>Depression and memory impairment: a meta-analysis of the association, its pattern, and specificity.</article-title>
<source/><italic>Psychol. Bull.</italic>
<volume>117</volume>
<fpage>285</fpage>–<lpage>305</lpage>. <pub-id pub-id-type="doi">10.1037/0033-2909.117.2.285</pub-id>
<pub-id pub-id-type="pmid">7724692</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Channon</surname><given-names>S.</given-names></name><name><surname>Green</surname><given-names>P. S.</given-names></name></person-group> (<year>1999</year>). <article-title>Executive function in depression: the role of performance strategies in aiding depressed and non-depressed participants.</article-title>
<source/><italic>J. Neurol. Neurosurg. Psychiatry.</italic>
<volume>66</volume>
<fpage>162</fpage>–<lpage>171</lpage>. <pub-id pub-id-type="pmid">10071094</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheetham</surname><given-names>S. C.</given-names></name><name><surname>Crompton</surname><given-names>M. R.</given-names></name><name><surname>Katona</surname><given-names>C. L.</given-names></name><name><surname>Horton</surname><given-names>R. W.</given-names></name></person-group> (<year>1990</year>). <article-title>Brain 5-HT1 binding sites in depressed suicides.</article-title>
<source/><italic>Psychopharmacology (Berl)</italic>
<volume>102</volume>
<fpage>544</fpage>–<lpage>548</lpage>. <pub-id pub-id-type="doi">10.1007/BF02247138</pub-id><pub-id pub-id-type="pmid">2096412</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>L.</given-names></name><name><surname>Sarna</surname><given-names>A.</given-names></name><name><surname>Goodwin</surname><given-names>G. M.</given-names></name></person-group> (<year>2005</year>). <article-title>Impairment of executive function but not memory in first-degree relatives of patients with bipolar I disorder and in euthymic patients with unipolar depression.</article-title>
<source/><italic>Am. J. Psychiatry</italic>
<volume>162</volume>
<fpage>1980</fpage>–<lpage>1982</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.162.10.1980</pub-id>
<pub-id pub-id-type="pmid">16199852</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>M. A.</given-names></name><name><surname>McIntyre</surname><given-names>K. E.</given-names></name><name><surname>Huhman</surname><given-names>K. L.</given-names></name></person-group> (<year>2008</year>). <article-title>Activation of 5-HT<sub>1A</sub> autoreceptors in the dorsal raphe nucleus reduces the behavioral consequences of social defeat.</article-title>
<source/><italic>Psychoneuroendocrinology</italic>
<volume>33</volume>
<fpage>1236</fpage>–<lpage>1247</lpage>. <pub-id pub-id-type="doi">10.1016/j.psyneuen.2008.06.009</pub-id>
<pub-id pub-id-type="pmid">18692968</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crane</surname><given-names>N. A.</given-names></name><name><surname>Jenkins</surname><given-names>L. M.</given-names></name><name><surname>Bhaumik</surname><given-names>R.</given-names></name><name><surname>Dion</surname><given-names>C.</given-names></name><name><surname>Gowins</surname><given-names>J. R.</given-names></name><name><surname>Mickey</surname><given-names>B. J.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Multidimensional prediction of treatment response to antidepressants with cognitive control and functional MRI.</article-title>
<source/><italic>Brain</italic>
<volume>140</volume>
<fpage>472</fpage>–<lpage>486</lpage>. <pub-id pub-id-type="doi">10.1093/brain/aww326</pub-id>
<pub-id pub-id-type="pmid">28122876</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuthbert</surname><given-names>B. N.</given-names></name></person-group> (<year>2005</year>). <article-title>Dimensional models of psychopathology: research agenda and clinical utility.</article-title>
<source/><italic>J. Abnorm. Psychol.</italic>
<volume>114</volume>
<fpage>565</fpage>–<lpage>569</lpage>. <pub-id pub-id-type="doi">10.1037/0021-843X.114.4.565</pub-id>
<pub-id pub-id-type="pmid">16351380</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Czyrak</surname><given-names>A.</given-names></name><name><surname>Czepiel</surname><given-names>K.</given-names></name><name><surname>Mackowiak</surname><given-names>M.</given-names></name><name><surname>Chocyk</surname><given-names>A.</given-names></name><name><surname>Wedzony</surname><given-names>K.</given-names></name></person-group> (<year>2003</year>). <article-title>Serotonin 5-HT<sub>1A</sub> receptors might control the output of cortical glutamatergic neurons in rat cingulate cortex.</article-title>
<source/><italic>Brain Res.</italic>
<volume>989</volume>
<fpage>42</fpage>–<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-8993(03)03352-3</pub-id><pub-id pub-id-type="pmid">14519510</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dannlowski</surname><given-names>U.</given-names></name><name><surname>Ohrmann</surname><given-names>P.</given-names></name><name><surname>Bauer</surname><given-names>J.</given-names></name><name><surname>Deckert</surname><given-names>J.</given-names></name><name><surname>Hohoff</surname><given-names>C.</given-names></name><name><surname>Kugel</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>5-HTTLPR biases amygdala activity in response to masked facial expressions in major depression.</article-title>
<source/><italic>Neuropsychopharmacology</italic>
<volume>33</volume>
<fpage>418</fpage>–<lpage>424</lpage>. <pub-id pub-id-type="doi">10.1038/sj.npp.1301411</pub-id>
<pub-id pub-id-type="pmid">17406646</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dawson</surname><given-names>E. L.</given-names></name><name><surname>Caveney</surname><given-names>A. F.</given-names></name><name><surname>Meyers</surname><given-names>K. K.</given-names></name><name><surname>Weisenbach</surname><given-names>S. L.</given-names></name><name><surname>Giordani</surname><given-names>B.</given-names></name><name><surname>Avery</surname><given-names>E. T.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Executive functioning at baseline prospectively predicts depression treatment response.</article-title>
<source/><italic>The Primary Prim. Care Companion</italic>
<volume>19</volume>
<fpage>e1</fpage>–<lpage>e7</lpage>. <pub-id pub-id-type="doi">10.4088/PCC.16m01949</pub-id>
<pub-id pub-id-type="pmid">28196313</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Disner</surname><given-names>S. G.</given-names></name><name><surname>Beevers</surname><given-names>C. G.</given-names></name><name><surname>Haigh</surname><given-names>E. A.</given-names></name><name><surname>Beck</surname><given-names>A. T.</given-names></name></person-group> (<year>2011</year>). <article-title>Neural mechanisms of the cognitive model of depression.</article-title>
<source/><italic>Nat. Rev. Neurosci.</italic>
<volume>12</volume>
<fpage>467</fpage>–<lpage>477</lpage>. <pub-id pub-id-type="doi">10.1038/nrn3027</pub-id>
<pub-id pub-id-type="pmid">21731066</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drevets</surname><given-names>W. C.</given-names></name><name><surname>Thase</surname><given-names>M. E.</given-names></name><name><surname>Kolko-Moses</surname><given-names>E. L.</given-names></name><name><surname>Price</surname><given-names>J.</given-names></name><name><surname>Frank</surname><given-names>E.</given-names></name><name><surname>Kupfer</surname><given-names>D. J.</given-names></name></person-group> (<year>2007</year>). <article-title>Serotonin-1A receptor imaging in recurrent depression: replication and literature review.</article-title>
<source/><italic>Nucl. Med. Biol.</italic>
<volume>34</volume>
<fpage>865</fpage>–<lpage>877</lpage>. <pub-id pub-id-type="doi">10.1016/j.nucmedbio.2007.06.008</pub-id>
<pub-id pub-id-type="pmid">17921037</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drysdale</surname><given-names>A. T.</given-names></name><name><surname>Grosenick</surname><given-names>L.</given-names></name><name><surname>Downar</surname><given-names>J.</given-names></name><name><surname>Dunlop</surname><given-names>K.</given-names></name><name><surname>Mansouri</surname><given-names>F.</given-names></name><name><surname>Meng</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Resting-state connectivity biomarkers define neurophysiological subtypes of depression.</article-title>
<source/><italic>Nat. Med.</italic>
<volume>23</volume>
<fpage>28</fpage>–<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1038/nm.4246</pub-id>
<pub-id pub-id-type="pmid">27918562</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elton</surname><given-names>A.</given-names></name><name><surname>Tripathi</surname><given-names>S. P.</given-names></name><name><surname>Mletzko</surname><given-names>T.</given-names></name><name><surname>Young</surname><given-names>J.</given-names></name><name><surname>Cisler</surname><given-names>J. M.</given-names></name><name><surname>James</surname><given-names>G. A.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Childhood maltreatment is associated with a sex-dependent functional reorganization of a brain inhibitory control network.</article-title>
<source/><italic>Hum. Brain Mapp.</italic>
<volume>35</volume>
<fpage>1654</fpage>–<lpage>1667</lpage>. <pub-id pub-id-type="doi">10.1002/hbm.22280</pub-id>
<pub-id pub-id-type="pmid">23616424</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flugge</surname><given-names>G.</given-names></name></person-group> (<year>1995</year>). <article-title>Dynamics of central nervous 5-HT<sub>1A</sub>-receptors under psychosocial stress.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>15</volume>
<fpage>7132</fpage>–<lpage>7140</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.15-11-07132.1995</pub-id><pub-id pub-id-type="pmid">7472467</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fusar-Poli</surname><given-names>P.</given-names></name><name><surname>Allen</surname><given-names>P.</given-names></name><name><surname>McGuire</surname><given-names>P.</given-names></name><name><surname>Placentino</surname><given-names>A.</given-names></name><name><surname>Cortesi</surname><given-names>M.</given-names></name><name><surname>Perez</surname><given-names>J.</given-names></name></person-group> (<year>2006</year>). <article-title>Neuroimaging and electrophysiological studies of the effects of acute tryptophan depletion: a systematic review of the literature.</article-title>
<source/><italic>Psychopharmacology</italic>
<volume>188</volume>
<fpage>131</fpage>–<lpage>143</lpage>. <pub-id pub-id-type="doi">10.1007/s00213-006-0493-1</pub-id>
<pub-id pub-id-type="pmid">16915379</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gotlib</surname><given-names>I. H.</given-names></name><name><surname>Joormann</surname><given-names>J.</given-names></name><name><surname>Minor</surname><given-names>K. L.</given-names></name><name><surname>Hallmayer</surname><given-names>J.</given-names></name></person-group> (<year>2008</year>). <article-title>HPA axis reactivity: a mechanism underlying the associations among 5-HTTLPR, stress, and depression.</article-title>
<source/><italic>Biological Biol. Psychiatry The Serotonin Transporter Gene and Stress Reactivity: Reflections on Altered Amygdala Reactivity</italic>
<volume>63</volume>
<fpage>847</fpage>–<lpage>851</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2007.10.008</pub-id>
<pub-id pub-id-type="pmid">18005940</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gross</surname><given-names>C.</given-names></name><name><surname>Zhuang</surname><given-names>X.</given-names></name><name><surname>Stark</surname><given-names>K.</given-names></name><name><surname>Ramboz</surname><given-names>S.</given-names></name><name><surname>Oosting</surname><given-names>R.</given-names></name><name><surname>Kirby</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult.</article-title>
<source/><italic>Nature</italic>
<volume>416</volume>
<fpage>396</fpage>–<lpage>400</lpage>. <pub-id pub-id-type="doi">10.1038/416396a</pub-id>
<pub-id pub-id-type="pmid">11919622</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gur</surname><given-names>R. C.</given-names></name><name><surname>Edwin</surname><given-names>R.</given-names></name><name><surname>Gur</surname><given-names>R.</given-names></name><name><surname>Zwil</surname><given-names>A.</given-names></name><name><surname>Heimberg</surname><given-names>C.</given-names></name><name><surname>Kraemer</surname><given-names>H.</given-names></name></person-group> (<year>1992</year>). <article-title>Facial emotion discrimination: II Behavioral findings in depression.</article-title>
<source/><italic>Psychiatry Research Res.</italic>
<volume>42</volume>
<fpage>241</fpage>–<lpage>251</lpage>. <pub-id pub-id-type="doi">10.1016/0165-1781(92)90116-K</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haddjeri</surname><given-names>N.</given-names></name><name><surname>Blier</surname><given-names>P.</given-names></name><name><surname>de Montigny</surname><given-names>C.</given-names></name></person-group> (<year>1998</year>). <article-title>Montigny, Long-term antidepressant treatments result in a tonic activation of forebrain 50HT1A receptors.</article-title>
<source/><italic>Journal J. of Neuroscience.</italic>
<volume>18</volume>
<fpage>10150</fpage>–<lpage>10156</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.18-23-10150.1998</pub-id>
<pub-id pub-id-type="pmid">9822768</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamilton</surname><given-names>J. P.</given-names></name><name><surname>Sacchet</surname><given-names>M. D.</given-names></name><name><surname>Hjørnevik</surname><given-names>T.</given-names></name><name><surname>Chin</surname><given-names>F. T.</given-names></name><name><surname>Shen</surname><given-names>B.</given-names></name><name><surname>Kämpe</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Striatal dopamine deficits predict reductions in striatal functional connectivity in major depression: a concurrent 11C-raclopride positron emission tomography and functional magnetic resonance imaging investigation.</article-title>
<source/><italic>Translational Transl. Psychiatry</italic>
<volume>8</volume> :<issue>264</issue>. <pub-id pub-id-type="doi">10.1038/s41398-018-0316-2</pub-id>
<pub-id pub-id-type="pmid">30504860</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamilton</surname><given-names>M.</given-names></name></person-group> (<year>1960</year>). <article-title>A rating scale for depression.</article-title>
<source/><italic>J. Neurol. Neurosurg. Psychiatry</italic>
<volume>23</volume>
<fpage>56</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1136/jnnp.23.1.56</pub-id><pub-id pub-id-type="pmid">14399272</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hariri</surname><given-names>A. R.</given-names></name><name><surname>Drabant</surname><given-names>E. M.</given-names></name><name><surname>Weinberger</surname><given-names>D. R.</given-names></name></person-group> (<year>2006</year>). <article-title>Imaging genetics: perspectives from studies of genetically driven variation in serotonin function and corticolimbic affective processing.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>59</volume>
<fpage>888</fpage>–<lpage>897</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2005.11.005</pub-id>
<pub-id pub-id-type="pmid">16442081</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hariri</surname><given-names>A. R.</given-names></name><name><surname>Mattay</surname><given-names>V. S.</given-names></name><name><surname>Tessitore</surname><given-names>A.</given-names></name><name><surname>Kolachana</surname><given-names>B.</given-names></name><name><surname>Fera</surname><given-names>F.</given-names></name><name><surname>Goldman</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>Serotonin transporter genetic variation and the response of the human amygdala.</article-title>
<source/><italic>Science</italic>
<volume>297</volume>
<fpage>400</fpage>–<lpage>403</lpage>. <pub-id pub-id-type="doi">10.1126/science.1071829</pub-id>
<pub-id pub-id-type="pmid">12130784</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heller</surname><given-names>W.</given-names></name><name><surname>Nitschke</surname><given-names>J.</given-names></name></person-group> (<year>1998</year>). <article-title>The puzzle of regional brain activity in depression and anxiety: the importance of subtypes and co-morbidity.</article-title>
<source/><italic>Cognition Cogn. &amp; Emotion.</italic>
<volume>12</volume>
<fpage>421</fpage>–<lpage>447</lpage>. <pub-id pub-id-type="doi">10.1080/026999398379664</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hensler</surname><given-names>J. G.</given-names></name><name><surname>Advani</surname><given-names>T.</given-names></name><name><surname>Monteggia</surname><given-names>L. M.</given-names></name></person-group> (<year>2007</year>). <article-title>Regulation of serotonin-1A receptor function in inducible brain-derived neurotrophic factor knockout mice after administration of corticosterone.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>62</volume>
<fpage>521</fpage>–<lpage>529</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2006.10.015</pub-id>
<pub-id pub-id-type="pmid">17336942</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirvonen</surname><given-names>J.</given-names></name><name><surname>Karlsson</surname><given-names>H.</given-names></name><name><surname>Kajander</surname><given-names>J.</given-names></name><name><surname>Lepola</surname><given-names>A.</given-names></name><name><surname>Markkula</surname><given-names>J.</given-names></name><name><surname>Rasi</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Decreased brain serotonin 5-HT<sub>1A</sub> receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635.</article-title>
<source/><italic>International Int. Journal J. of Neuropsychopharmacology.</italic>
<volume>11</volume>
<fpage>465</fpage>–<lpage>476</lpage>. <pub-id pub-id-type="doi">10.1017/S1461145707008140</pub-id>
<pub-id pub-id-type="pmid">17971260</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>C. S.</given-names></name><name><surname>Zhang</surname><given-names>M. W.</given-names></name><name><surname>Ho</surname><given-names>R. C.</given-names></name></person-group> (<year>2016</year>). <article-title>Optical topography in psychiatry: a chip off the old block or a new look beyond the mind-brain frontiers?</article-title>
<source/><italic>Front. Psychiatry</italic>
<volume>7</volume>:<issue>74</issue>. <pub-id pub-id-type="doi">10.3389/fpsyt.2016.00074</pub-id>
<pub-id pub-id-type="pmid">27199781</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>R. C. M.</given-names></name><name><surname>Chua</surname><given-names>A. C.</given-names></name><name><surname>Tran</surname><given-names>B. X.</given-names></name><name><surname>Choo</surname><given-names>C. C.</given-names></name><name><surname>Husain</surname><given-names>S. F.</given-names></name><name><surname>Vu</surname><given-names>G. T.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Factors associated with the risk of developing coronary artery disease in medicated patients with major depressive disorder.</article-title>
<source/><italic>International Int. Journal J. of Environmental. Research Res. and Public Health</italic>
<volume>15</volume> :<issue>E2073</issue>. <pub-id pub-id-type="doi">10.3390/ijerph15102073</pub-id>
<pub-id pub-id-type="pmid">30248896</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>D. T.</given-names></name><name><surname>Langenecker</surname><given-names>S.</given-names></name><name><surname>Kennedy</surname><given-names>S.</given-names></name><name><surname>Zubieta</surname><given-names>J.</given-names></name><name><surname>Heitzeg</surname><given-names>M. M.</given-names></name></person-group> (<year>2010</year>). <article-title>fMRI BOLD responses to negative stimuli in the prefrontal cortex are dependent on levels of recent negative life stress in major depressive disorder.</article-title>
<source/><italic>Psychiatry Research:. Neuroimaging</italic>
<volume>183</volume>
<fpage>7202</fpage>–<lpage>208</lpage>. <pub-id pub-id-type="doi">10.1016/j.pscychresns.2009.12.002</pub-id>
<pub-id pub-id-type="pmid">20685091</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hugdahl</surname><given-names>K.</given-names></name><name><surname>Rund</surname><given-names>B. R.</given-names></name><name><surname>Lund</surname><given-names>A.</given-names></name><name><surname>Asbjornsen</surname><given-names>A.</given-names></name><name><surname>Egeland</surname><given-names>J.</given-names></name><name><surname>Landro</surname><given-names>N. I.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Attentional and executive dysfunctions in schizophrenia and depression: evidence from dichotic listening performance.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>53</volume>
<fpage>609</fpage>–<lpage>616</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-3223(02)01598-6</pub-id>
<pub-id pub-id-type="pmid">12679239</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname><given-names>D. R.</given-names></name><name><surname>Simpson</surname><given-names>N. R.</given-names></name><name><surname>Montoya</surname><given-names>J.</given-names></name><name><surname>Man</surname><given-names>J. J.</given-names></name><name><surname>Laruelle</surname><given-names>M.</given-names></name></person-group> (<year>1999</year>). <article-title>An improved one-pot procedure for the preparation of [11C-carbonyl]-WAY100635.</article-title>
<source/><italic>Nucl. Med. Biol.</italic>
<volume>26</volume>
<fpage>815</fpage>–<lpage>819</lpage>. <pub-id pub-id-type="doi">10.1016/S0969-8051(99)00056-6</pub-id><pub-id pub-id-type="pmid">10628562</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Insel</surname><given-names>T.</given-names></name><name><surname>Cuthbert</surname><given-names>B.</given-names></name><name><surname>Garvey</surname><given-names>M.</given-names></name><name><surname>Heinssen</surname><given-names>R.</given-names></name><name><surname>Pine</surname><given-names>D. S.</given-names></name><name><surname>Quinn</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Research domain criteria (RDoC): toward a new classification framework for research on mental disorders.</article-title>
<source/><italic>Am. J. Psychiatry</italic>
<volume>167</volume>
<fpage>748</fpage>–<lpage>751</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.2010.09091379</pub-id>
<pub-id pub-id-type="pmid">20595427</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacobs</surname><given-names>N.</given-names></name><name><surname>Kenis</surname><given-names>G.</given-names></name><name><surname>Peeters</surname><given-names>F.</given-names></name><name><surname>Derom</surname><given-names>C.</given-names></name><name><surname>Vlietinck</surname><given-names>R.</given-names></name><name><surname>van</surname><given-names>J.</given-names></name></person-group> (<year>2006</year>). <article-title>Os, stress-related negative affectivity and genetically altered serotonin transporter function: evidence of synergism in shaping risk of depression.</article-title>
<source/><italic>Arch. Gen. Psychiatry</italic>
<volume>63</volume>
<fpage>989</fpage>–<lpage>996</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.63.9.989</pub-id>
<pub-id pub-id-type="pmid">16953001</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaeger</surname><given-names>J.</given-names></name><name><surname>Berns</surname><given-names>S.</given-names></name><name><surname>Loftus</surname><given-names>S.</given-names></name><name><surname>Gonzalez</surname><given-names>C.</given-names></name><name><surname>Czobor</surname><given-names>P.</given-names></name></person-group> (<year>2007</year>). <article-title>Neurocognitive test performance predicts functional recovery from acute exacerbation leading to hospitalization in bipolar disorder 87.</article-title>
<source/><italic>Bipolar. Disord.</italic>
<volume>9</volume>
<fpage>93</fpage>–<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1111/j.1399-5618.2007.00427.x</pub-id>
<pub-id pub-id-type="pmid">17391353</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Januel</surname><given-names>D.</given-names></name><name><surname>Dumortier</surname><given-names>G.</given-names></name><name><surname>Verdon</surname><given-names>C. M.</given-names></name><name><surname>Stamatiadis</surname><given-names>L.</given-names></name><name><surname>Saba</surname><given-names>G.</given-names></name><name><surname>Cabaret</surname><given-names>W.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>A double-blind sham controlled study of right prefrontal repetitive transcranial magnetic stimulation (rTMS): therapeutic and cognitive effect in medication free unipolar depression during 4 weeks.</article-title>
<source/><italic>Progress Prog. in Neuro-Psychopharmacology psychopharmacol. and Biological. Psychiatry</italic>
<volume>30</volume>
<fpage>126</fpage>–<lpage>130</lpage>. <pub-id pub-id-type="pmid">16242826</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jovanovic</surname><given-names>H.</given-names></name><name><surname>Lundberg</surname><given-names>J.</given-names></name><name><surname>Karlsson</surname><given-names>P.</given-names></name><name><surname>Cerin</surname><given-names>A.</given-names></name><name><surname>Saijo</surname><given-names>T.</given-names></name><name><surname>Varrone</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET.</article-title>
<source/><italic>Neuroimage</italic>
<volume>39</volume>
<fpage>1408</fpage>–<lpage>1419</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2007.10.016</pub-id>
<pub-id pub-id-type="pmid">18036835</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalia</surname><given-names>M.</given-names></name></person-group> (<year>2005</year>). <article-title>Neurobiological basis of depression: an update.</article-title>
<source/><italic>Metabolism</italic>
<volume>54</volume>
<fpage>24</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1016/j.metabol.2005.01.009</pub-id>
<pub-id pub-id-type="pmid">15877309</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalin</surname><given-names>N. H.</given-names></name><name><surname>Shelton</surname><given-names>S. E.</given-names></name><name><surname>Fox</surname><given-names>A. S.</given-names></name><name><surname>Rogers</surname><given-names>J.</given-names></name><name><surname>Oakes</surname><given-names>T. R.</given-names></name><name><surname>Davidson</surname><given-names>R. J.</given-names></name></person-group> (<year>2008</year>). <article-title>The serotonin transporter genotype is associated with intermediate brain phenotypes that depend on the context of eliciting stressor.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>13</volume>
<fpage>1021</fpage>–<lpage>1027</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2008.37</pub-id>
<pub-id pub-id-type="pmid">18414408</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kampf-Sherf</surname><given-names>O.</given-names></name><name><surname>Zlotogorski</surname><given-names>Z.</given-names></name><name><surname>Gilboa</surname><given-names>A.</given-names></name><name><surname>Speedie</surname><given-names>L.</given-names></name><name><surname>Lereya</surname><given-names>J.</given-names></name><name><surname>Rosca</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Neuropsychological functioning in major depression and responsiveness to selective serotonin reuptake inhibitors antidepressants.</article-title>
<source/><italic>Journal J. of Affective. Disorders Disord.</italic>
<volume>82</volume>
<fpage>453</fpage>–<lpage>459</lpage>. <pub-id pub-id-type="doi">10.1016/j.jad.2004.02.006</pub-id>
<pub-id pub-id-type="pmid">15555698</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaufman</surname><given-names>J.</given-names></name><name><surname>Sullivan</surname><given-names>G. M.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Ogden</surname><given-names>R. T.</given-names></name><name><surname>Miller</surname><given-names>J. M.</given-names></name><name><surname>Oquendo</surname><given-names>M. A.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Quantification of the serotonin 1A receptor using PET: identification of a potential biomarker of major depression in males.</article-title>
<source/><italic>Neuropsychopharmacology</italic>
<volume>40</volume>
<fpage>1692</fpage>–<lpage>1699</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2015.15</pub-id>
<pub-id pub-id-type="pmid">25578798</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kautzky</surname><given-names>A.</given-names></name><name><surname>Hahn</surname><given-names>A.</given-names></name><name><surname>Godbersen</surname><given-names>G. M.</given-names></name><name><surname>Gryglewski</surname><given-names>G.</given-names></name><name><surname>James</surname><given-names>G. M.</given-names></name><name><surname>Sigurdardottir</surname><given-names>H. L.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Parcellation of the human cerebral cortex based on molecular targets in the serotonin system quantified by positron emission tomography in vivo.</article-title>
<source/><italic>Cerebral Cereb. Cortex</italic>
<volume>29</volume>
<fpage>372</fpage>–<lpage>382</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/bhy249</pub-id>
<pub-id pub-id-type="pmid">30357321</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kautzky</surname><given-names>A.</given-names></name><name><surname>James</surname><given-names>G. M.</given-names></name><name><surname>Philippe</surname><given-names>C.</given-names></name><name><surname>Baldinger-Melich</surname><given-names>P.</given-names></name><name><surname>Kraus</surname><given-names>C.</given-names></name><name><surname>Kranz</surname><given-names>G. S.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>The influence of the rs6295 gene polymorphism on serotonin-1A receptor distribution investigated with PET in patients with major depression applying machine learning.</article-title>
<source/><italic>Transl. Psychiatry</italic>
<volume>7</volume> :e1150. <pub-id pub-id-type="doi">10.1038/tp.2017.108</pub-id>
<pub-id pub-id-type="pmid">28608854</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kepe</surname><given-names>V.</given-names></name><name><surname>Barrio</surname><given-names>J. R.</given-names></name><name><surname>Huang</surname><given-names>S. C.</given-names></name><name><surname>Ercoli</surname><given-names>L.</given-names></name><name><surname>Siddarth</surname><given-names>P.</given-names></name><name><surname>Shoghi</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Serotonin 1A receptors in the living brain of Alzheimer’s disease patients.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>103</volume>
<fpage>702</fpage>–<lpage>707</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0510237103</pub-id>
<pub-id pub-id-type="pmid">16407119</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kling</surname><given-names>L. R.</given-names></name><name><surname>Bessette</surname><given-names>K. L.</given-names></name><name><surname>DelDonno</surname><given-names>S. R.</given-names></name><name><surname>Ryan</surname><given-names>K. A.</given-names></name><name><surname>Drevets</surname><given-names>W. C.</given-names></name><name><surname>McInnis</surname><given-names>M. G.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Cluster analysis with MOODS-SR illustrates a potential bipolar disorder risk phenotype in young adults with remitted major depressive disorder.</article-title>
<source/><italic>Bipolar Disord.</italic>
<volume>20</volume>
<fpage>697</fpage>–<lpage>707</lpage>. <pub-id pub-id-type="doi">10.1111/bdi.12693</pub-id>
<pub-id pub-id-type="pmid">30294823</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kranz</surname><given-names>G. S.</given-names></name><name><surname>Hahn</surname><given-names>A.</given-names></name><name><surname>Kraus</surname><given-names>C.</given-names></name><name><surname>Spies</surname><given-names>M.</given-names></name><name><surname>Pichler</surname><given-names>V.</given-names></name><name><surname>Jungwirth</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Probing the association between serotonin-1A autoreceptor binding and amygdala reactivity in healthy volunteers.</article-title>
<source/><italic>Neuroimage</italic>
<volume>171</volume>
<fpage>1</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2017.12.092</pub-id>
<pub-id pub-id-type="pmid">29292133</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kranz</surname><given-names>G. S.</given-names></name><name><surname>Kasper</surname><given-names>S.</given-names></name><name><surname>Lanzenberger</surname><given-names>R.</given-names></name></person-group> (<year>2010</year>). <article-title>Reward and the serotonergic system.</article-title>
<source/><italic>Neuroscience</italic>
<volume>166</volume>
<fpage>1023</fpage>–<lpage>1035</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2010.01.036</pub-id>
<pub-id pub-id-type="pmid">20109531</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kraus</surname><given-names>C.</given-names></name><name><surname>Hahn</surname><given-names>A.</given-names></name><name><surname>Savli</surname><given-names>M.</given-names></name><name><surname>Kranz</surname><given-names>G. S.</given-names></name><name><surname>Baldinger</surname><given-names>P.</given-names></name><name><surname>Hoflich</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Serotonin-1A receptor binding is positively associated with gray matter volume — A multimodal neuroimaging study combining PET and structural MRI.</article-title>
<source/><italic>Neuroimage</italic>
<volume>63</volume>
<fpage>1091</fpage>–<lpage>1098</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2012.07.035</pub-id>
<pub-id pub-id-type="pmid">22836176</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamar</surname><given-names>M.</given-names></name><name><surname>Cutter</surname><given-names>W. J.</given-names></name><name><surname>Rubia</surname><given-names>K.</given-names></name><name><surname>Brammer</surname><given-names>M.</given-names></name><name><surname>Daly</surname><given-names>E. M.</given-names></name><name><surname>Craig</surname><given-names>M. C.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>5-HT, prefrontal function and aging: fMRI of inhibition and acute tryptophan depletion.</article-title>
<source/><italic>Neurobiol. Aging</italic>
<volume>30</volume>
<fpage>1135</fpage>–<lpage>1146</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2007.09.013</pub-id>
<pub-id pub-id-type="pmid">18061310</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langenecker</surname><given-names>S. A.</given-names></name></person-group> (<year>2001</year>). <article-title>The neuroanatomy of inhibitory control in healthy aging: Evidence from eventrelated fMRI.</article-title>
<comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://epublications.marquette.edu/dissertations/AAI3049934">https://epublications.marquette.edu/dissertations/AAI3049934</ext-link></comment></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langenecker</surname><given-names>S. A.</given-names></name><name><surname>Bieliauskas</surname><given-names>L. A.</given-names></name><name><surname>Rapport</surname><given-names>L. J.</given-names></name><name><surname>Zubieta</surname><given-names>J. K.</given-names></name><name><surname>Wilde</surname><given-names>E. A.</given-names></name><name><surname>Berent</surname><given-names>S.</given-names></name></person-group> (<year>2005</year>). <article-title>Face emotion perception and executive functioning deficits in depression.</article-title>
<source/><italic>J. Clin. Exp. Neuropsychol.</italic>
<volume>27</volume>
<fpage>320</fpage>–<lpage>333</lpage>. <pub-id pub-id-type="doi">10.1080/13803390490490515720</pub-id>
<pub-id pub-id-type="pmid">15969355</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langenecker</surname><given-names>S. A.</given-names></name><name><surname>Briceno</surname><given-names>E. M.</given-names></name><name><surname>Hamid</surname><given-names>N. M.</given-names></name><name><surname>Nielson</surname><given-names>K. A.</given-names></name></person-group> (<year>2007a</year>). <article-title>An evaluation of distinct volumetric and functional MRI contributions toward understanding age and task performance: a study in the basal ganglia.</article-title>
<source/><italic>Brain Res.</italic>
<volume>1135</volume>
<fpage>58</fpage>–<lpage>68</lpage>. <pub-id pub-id-type="pmid">17210145</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langenecker</surname><given-names>S. A.</given-names></name><name><surname>Caveney</surname><given-names>A. F.</given-names></name><name><surname>Giordani</surname><given-names>B.</given-names></name><name><surname>Young</surname><given-names>E. A.</given-names></name><name><surname>Nielson</surname><given-names>K. A.</given-names></name><name><surname>Rapport</surname><given-names>L. J.</given-names></name><etal></etal></person-group> (<year>2007b</year>). <article-title>The sensitivity and psychometric properties of a brief computer-based cognitive screening battery in a depression clinic.</article-title>
<source/><italic>Psychiatry Research Res.</italic>
<volume>152</volume>
<fpage>143</fpage>–<lpage>154</lpage>. <pub-id pub-id-type="pmid">17445911</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langenecker</surname><given-names>S. A.</given-names></name><name><surname>Kennedy</surname><given-names>S. E.</given-names></name><name><surname>Guidotti</surname><given-names>L. M.</given-names></name><name><surname>Briceno</surname><given-names>E. M.</given-names></name><name><surname>Own</surname><given-names>L. S.</given-names></name><name><surname>Hooven</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2007c</year>). <article-title>Frontal and limbic activation during inhibitory control predicts treatment response in major depressive disorder.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>62</volume>
<fpage>1272</fpage>–<lpage>1280</lpage>. <pub-id pub-id-type="pmid">17585888</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langenecker</surname><given-names>S. A.</given-names></name><name><surname>Zubieta</surname><given-names>J. K.</given-names></name><name><surname>Young</surname><given-names>E. A.</given-names></name><name><surname>Akil</surname><given-names>H.</given-names></name><name><surname>Nielson</surname><given-names>K. A.</given-names></name></person-group> (<year>2007d</year>). <article-title>A task to manipulate attentional load, set-shifting, and inhibitory control: convergent validity and test-retest reliability of the Parametric Go/No-Go Test.</article-title>
<source/><italic>J. Clin. Exp. Neuropsychol.</italic>
<volume>29</volume>
<fpage>842</fpage>–<lpage>853</lpage>. <pub-id pub-id-type="pmid">17852593</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langenecker</surname><given-names>S. A.</given-names></name><name><surname>Jacobs</surname><given-names>R. H.</given-names></name><name><surname>Passarotti</surname><given-names>A. M.</given-names></name></person-group> (<year>2014</year>). <article-title>Current neural and behavioral dimensional constructs across mood disorders.</article-title>
<source/><italic>Current Curr. Behavioral Behav. Neuroscience Neurosci. ReportsRep.</italic><sup>∗</sup>
<volume>1</volume>
<fpage>114</fpage>–<lpage>153</lpage>. <pub-id pub-id-type="pmid">25147755</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langenecker</surname><given-names>S. A.</given-names></name><name><surname>Jenkins</surname><given-names>L. M.</given-names></name><name><surname>Stange</surname><given-names>J. P.</given-names></name><name><surname>Chang</surname><given-names>Y. S.</given-names></name><name><surname>DelDonno</surname><given-names>S. R.</given-names></name><name><surname>Bessette</surname><given-names>K. L.</given-names></name><etal></etal></person-group> (<year>2018a</year>). <article-title>Cognitive control neuroimaging measures differentiate between those with and without future recurrence of depression.</article-title>
<source/><italic>Neuroimage: Clinical Clin.</italic>
<volume>20</volume>
<fpage>1001</fpage>–<lpage>1009</lpage>. <pub-id pub-id-type="doi">10.1016/j.nicl.2018.10.004</pub-id>
<pub-id pub-id-type="pmid">30321791</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langenecker</surname><given-names>S. A.</given-names></name><name><surname>Klumpp</surname><given-names>H.</given-names></name><name><surname>Peters</surname><given-names>A. T.</given-names></name><name><surname>Crane</surname><given-names>N. A.</given-names></name><name><surname>DelDonno</surname><given-names>S. R.</given-names></name><name><surname>Bessette</surname><given-names>K. L.</given-names></name><etal></etal></person-group> (<year>2018b</year>). <article-title>Multidimensional imaging techniques for prediction of treatment response in major depressive disorder.</article-title>
<source/><italic>Progress Prog. in Neuro-psychopharmacology. and Biological. Psychiatry</italic>
<pub-id pub-id-type="doi">10.1016/j.pnpbp.2018.07.001</pub-id>
<comment>[Epub ahead of print]</comment>. <pub-id pub-id-type="pmid">30009871</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Langenecker</surname><given-names>S. A.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Bieliauskas</surname><given-names>L. A.</given-names></name></person-group> (<year>2009</year>). <article-title>“Neuropsychology of depression, and related mood disorders,” in</article-title>
<source/><italic>Neuropsychological Assessment of Neuropsychiatric and Neuromedical Disorders</italic>
<role>ed.</role>
<person-group person-group-type="editor"><name><surname>Adams</surname><given-names>I. G. K.</given-names></name></person-group> (<publisher-loc>Oxford</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>).</mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langenecker</surname><given-names>S. A.</given-names></name><name><surname>Saunders</surname><given-names>E. F. H.</given-names></name><name><surname>Kade</surname><given-names>A. M.</given-names></name><name><surname>Ransom</surname><given-names>M. T.</given-names></name><name><surname>McInnis</surname><given-names>M. G.</given-names></name></person-group> (<year>2010</year>). <article-title>Intermediate cognitive phenotypes in bipolar disorder.</article-title>
<source/><italic>J. Affect. Disord.</italic>
<volume>122</volume>
<fpage>285</fpage>–<lpage>293</lpage>. <pub-id pub-id-type="doi">10.1016/j.jad.2009.08.018</pub-id>
<pub-id pub-id-type="pmid">19800130</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>Y.</given-names></name><name><surname>Rosenblat</surname><given-names>J. D.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Carmona</surname><given-names>N. E.</given-names></name><name><surname>Subramaniapillai</surname><given-names>M.</given-names></name><name><surname>Shekotikhina</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Efficacy of antidepressants on measures of workplace functioning in major depressive disorder: a systematic review.</article-title>
<source/><italic>J. Affect. Disord.</italic>
<volume>227</volume>
<fpage>406</fpage>–<lpage>415</lpage>. <pub-id pub-id-type="doi">10.1016/j.jad.2017.11.003</pub-id>
<pub-id pub-id-type="pmid">29154157</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lesch</surname><given-names>K. P.</given-names></name><name><surname>Bengel</surname><given-names>D.</given-names></name><name><surname>Heils</surname><given-names>A.</given-names></name><name><surname>Sabol</surname><given-names>S. Z.</given-names></name><name><surname>Greenberg</surname><given-names>B. D.</given-names></name><name><surname>Petri</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>1996</year>). <article-title>Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region.</article-title>
<source/><italic>Science</italic>
<volume>274</volume>
<fpage>1527</fpage>–<lpage>1531</lpage>. <pub-id pub-id-type="doi">10.1126/science.274.5292.1527</pub-id><pub-id pub-id-type="pmid">8929413</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levkovitz</surname><given-names>Y.</given-names></name><name><surname>Harel</surname><given-names>E. V.</given-names></name><name><surname>Roth</surname><given-names>Y.</given-names></name><name><surname>Braw</surname><given-names>Y.</given-names></name><name><surname>Most</surname><given-names>D.</given-names></name><name><surname>Katz</surname><given-names>L. N.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Deep transcranial magnetic stimulation over the prefrontal cortex: evaluation of antidepressant and cognitive effects in depressive patients.</article-title>
<source/><italic>Brain Stimulation Stimul.</italic>
<volume>2</volume>
<fpage>188</fpage>–<lpage>200</lpage>. <pub-id pub-id-type="doi">10.1016/j.brs.2009.08.002</pub-id>
<pub-id pub-id-type="pmid">20633419</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>C. R.</given-names></name><name><surname>Barlas</surname><given-names>J.</given-names></name><name><surname>Ho</surname><given-names>R. C. M.</given-names></name></person-group> (<year>2018</year>). <article-title>The effects of temperament on depression according to the schema model: a scoping review.</article-title>
<source/><italic>International Int. Journal J. of Environmental. Research Res. and Public Health</italic>
<volume>15</volume> :<issue>E1231</issue>. <pub-id pub-id-type="doi">10.3390/ijerph15061231</pub-id>
<pub-id pub-id-type="pmid">29891793</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lima</surname><given-names>F. B.</given-names></name><name><surname>Centeno</surname><given-names>M. L.</given-names></name><name><surname>Costa</surname><given-names>M. E.</given-names></name><name><surname>Reddy</surname><given-names>A. P.</given-names></name><name><surname>Cameron</surname><given-names>J. L.</given-names></name><name><surname>Bethea</surname><given-names>C. L.</given-names></name></person-group> (<year>2009</year>). <article-title>Stress sensitive female macaques have decreased fifth Ewing variant (Fev) and serotonin-related gene expression that is not reversed by citalopram.</article-title>
<source/><italic>Neuroscience</italic>
<volume>164</volume>
<fpage>676</fpage>–<lpage>691</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2009.08.010</pub-id>
<pub-id pub-id-type="pmid">19671441</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Logan</surname><given-names>J.</given-names></name><name><surname>Fowler</surname><given-names>J. S.</given-names></name><name><surname>Volkow</surname><given-names>N. D.</given-names></name><name><surname>Wang</surname><given-names>G. J.</given-names></name><name><surname>Ding</surname><given-names>Y. S.</given-names></name><name><surname>Alexoff</surname><given-names>D. L.</given-names></name></person-group> (<year>1996</year>). <article-title>Distribution volume ratios without blood sampling from graphical analysis of PET data.</article-title>
<source/><italic>J. Cereb. Blood Flow Metab.</italic>
<volume>16</volume>
<fpage>834</fpage>–<lpage>840</lpage>. <pub-id pub-id-type="doi">10.1097/00004647-199609000-00008</pub-id>
<pub-id pub-id-type="pmid">8784228</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lohoff</surname><given-names>F. W.</given-names></name><name><surname>Hodge</surname><given-names>R.</given-names></name><name><surname>Narasimhan</surname><given-names>S.</given-names></name><name><surname>Nall</surname><given-names>A.</given-names></name><name><surname>Ferroro</surname><given-names>T. N.</given-names></name><name><surname>Mickey</surname><given-names>B. J.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Functional genetic variants in the vesicular monoamine transporter 1 (VMAT1) modulate emotion processing.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>19</volume>
<fpage>129</fpage>–<lpage>139</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2012.193</pub-id>
<pub-id pub-id-type="pmid">23337945</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez</surname><given-names>J. F.</given-names></name><name><surname>Chalmers</surname><given-names>D. T.</given-names></name><name><surname>Little</surname><given-names>K. Y.</given-names></name><name><surname>Watson</surname><given-names>S. J.</given-names></name></person-group> (<year>1998</year>). <article-title>Regulation of serotonin 1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>43</volume>
<fpage>547</fpage>–<lpage>573</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-3223(97)00484-8</pub-id><pub-id pub-id-type="pmid">9564441</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez</surname><given-names>J. F.</given-names></name><name><surname>Liberzon</surname><given-names>I.</given-names></name><name><surname>Vazquez</surname><given-names>D. M.</given-names></name><name><surname>Young</surname><given-names>E. A.</given-names></name><name><surname>Watson</surname><given-names>S. J.</given-names></name></person-group> (<year>1999</year>). <article-title>Serotonin 1A receptor messenger RNA regulation in the hippocampus after acute stress.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>45</volume>
<fpage>934</fpage>–<lpage>937</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-3223(98)00224-8</pub-id><pub-id pub-id-type="pmid">10202584</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lothe</surname><given-names>A.</given-names></name><name><surname>Saoud</surname><given-names>M.</given-names></name><name><surname>Bouvard</surname><given-names>S.</given-names></name><name><surname>Redout</surname><given-names>J.</given-names></name><name><surname>Lerond</surname><given-names>J.</given-names></name><name><surname>Ryvlin</surname><given-names>P.</given-names></name></person-group> (<year>2012</year>). <article-title>5-HT<sub>1A</sub> receptor binding changes in patients with major depressive disorder before and after antidepressant treatment: a pilot [18F]MPPF positron emission tomography study.</article-title>
<source/><italic>Psychiatry Research:. Neuroimaging</italic>
<volume>203</volume>
<fpage>103</fpage>–<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1016/j.pscychresns.2011.09.001</pub-id>
<pub-id pub-id-type="pmid">22863653</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>Y.</given-names></name><name><surname>Ho</surname><given-names>C. S.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Chua</surname><given-names>A. N.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>McIntyre</surname><given-names>R. S.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Chronic administration of fluoxetine and pro-inflammatory cytokine change in a rat model of depression.</article-title>
<source/><italic>PLoS One</italic>
<volume>12</volume>:<issue>e0186700</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0186700</pub-id>
<pub-id pub-id-type="pmid">29049348</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>Y.</given-names></name><name><surname>Ho</surname><given-names>C. S.</given-names></name><name><surname>McIntyre</surname><given-names>R. S.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Ho</surname><given-names>R. C.</given-names></name></person-group> (<year>2018a</year>). <article-title>Agomelatine-induced modulation of brain-derived neurotrophic factor (BDNF) in the rat hippocampus.</article-title>
<source/><italic>Life Sci.</italic>
<volume>210</volume>
<fpage>177</fpage>–<lpage>184</lpage>. <pub-id pub-id-type="doi">10.1016/j.lfs.2018.09.003</pub-id>
<pub-id pub-id-type="pmid">30193943</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>Y.</given-names></name><name><surname>Ho</surname><given-names>C. S.</given-names></name><name><surname>McIntyre</surname><given-names>R. S.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Ho</surname><given-names>R. C.</given-names></name></person-group> (<year>2018b</year>). <article-title>Effects of vortioxetine and fluoxetine on the level of Brain Derived Neurotrophic Factors (BDNF) in the hippocampus of chronic unpredictable mild stress-induced depressive rats.</article-title>
<source/><italic>Brain Res. Bull.</italic>
<volume>142</volume>
<fpage>1</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainresbull.2018.06.007</pub-id>
<pub-id pub-id-type="pmid">29933036</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mak</surname><given-names>K. K.</given-names></name><name><surname>Kong</surname><given-names>W. Y.</given-names></name><name><surname>Mak</surname><given-names>A.</given-names></name><name><surname>Sharma</surname><given-names>V. K.</given-names></name><name><surname>Ho</surname><given-names>R. C.</given-names></name></person-group> (<year>2013</year>). <article-title>Polymorphisms of the serotonin transporter gene and post-stroke depression: a meta-analysis.</article-title>
<source/><italic>J. Neurol. Neurosurg. Psychiatry</italic>
<volume>84</volume>
<fpage>322</fpage>–<lpage>328</lpage>. <pub-id pub-id-type="doi">10.1136/jnnp-2012-303791</pub-id>
<pub-id pub-id-type="pmid">23236014</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marazziti</surname><given-names>D.</given-names></name><name><surname>Marracci</surname><given-names>S.</given-names></name><name><surname>Palego</surname><given-names>L.</given-names></name><name><surname>Rotondo</surname><given-names>A.</given-names></name><name><surname>Mazzanti</surname><given-names>C.</given-names></name><name><surname>Nardi</surname><given-names>I.</given-names></name><etal></etal></person-group> (<year>1994</year>). <article-title>Localization and gene expression of serotonin 1A (5HT1A) receptors in human brain postmortem.</article-title>
<source/><italic>Brain Res.</italic>
<volume>658</volume>
<fpage>55</fpage>–<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-8993(09)90010-5</pub-id>
<pub-id pub-id-type="pmid">7834355</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKendrick</surname><given-names>R.</given-names></name><name><surname>Parasuraman</surname><given-names>R.</given-names></name><name><surname>Ayaz</surname><given-names>H.</given-names></name></person-group> (<year>2015</year>). <article-title>Wearable functional near infrared spectroscopy (fNIRS) and transcranial direct current stimulation (tDCS): expanding vistas for neurocognitive augmentation.</article-title>
<source/><italic>Front. Syst. Neurosci.</italic>
<volume>9</volume>:<issue>27</issue>. <pub-id pub-id-type="doi">10.3389/fnsys.2015.00027</pub-id>
<pub-id pub-id-type="pmid">25805976</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mickey</surname><given-names>B. J.</given-names></name><name><surname>Ducci</surname><given-names>F.</given-names></name><name><surname>Hodgkinson</surname><given-names>C.</given-names></name><name><surname>Langenecker</surname><given-names>S. A.</given-names></name><name><surname>Goldman</surname><given-names>D.</given-names></name><name><surname>Zubieta</surname><given-names>J. K.</given-names></name></person-group> (<year>2008</year>). <article-title>Monoamine oxidase A genotype predicts human serotonin 1A receptor availability in vivo.</article-title>
<source/><italic>Journal J. for Neuroscience.</italic>
<volume>28</volume>
<fpage>11354</fpage>–<lpage>11359</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2391-08.2008</pub-id>
<pub-id pub-id-type="pmid">18971477</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milak</surname><given-names>M. S.</given-names></name><name><surname>Pantazatos</surname><given-names>S.</given-names></name><name><surname>Rashid</surname><given-names>R.</given-names></name><name><surname>Zanderigo</surname><given-names>F.</given-names></name><name><surname>DeLorenzo</surname><given-names>C.</given-names></name><name><surname>Hesselgrave</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Higher 5-HT<sub>1A</sub> autoreceptor binding as an endophenotype for major depressive disorder identified in high risk offspring - A pilot study.</article-title>
<source/><italic>Psychiatry Research. Neuroimaging</italic>
<volume>276</volume>
<fpage>15</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/j.pscychresns.2018.04.002</pub-id>
<pub-id pub-id-type="pmid">29702461</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>J. M.</given-names></name><name><surname>Oquendo</surname><given-names>M. A.</given-names></name><name><surname>Ogden</surname><given-names>R. T.</given-names></name><name><surname>Mann</surname><given-names>J. J.</given-names></name><name><surname>Parsey</surname><given-names>R. V.</given-names></name></person-group> (<year>2008</year>). <article-title>Serotonin transporter binding as a possible predictor of one-year remission in major depressive disorder.</article-title>
<source/><italic>J. Psychiatr. Res.</italic>
<volume>42</volume>
<fpage>1137</fpage>–<lpage>1144</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpsychires.2008.01.012</pub-id>
<pub-id pub-id-type="pmid">18331740</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moses-Kolko</surname><given-names>E. L.</given-names></name><name><surname>Price</surname><given-names>J. C.</given-names></name><name><surname>Thase</surname><given-names>M. E.</given-names></name><name><surname>Meltzer</surname><given-names>C. C.</given-names></name><name><surname>Kupfer</surname><given-names>D. J.</given-names></name><name><surname>Mathis</surname><given-names>C. A.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Measurement of 5-HT<sub>1A</sub> receptor binding in depressed adults before and after antidepressant drug treatment using positron emission tomography and [11C]WAY-100635.</article-title>
<source/><italic>Synapse<sup>∗</sup></italic>
<volume>61</volume>
<fpage>523</fpage>–<lpage>530</lpage>. <pub-id pub-id-type="doi">10.1002/syn.20398</pub-id>
<pub-id pub-id-type="pmid">17447260</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naarding</surname><given-names>P.</given-names></name><name><surname>Leentjens</surname><given-names>A. F.</given-names></name><name><surname>van Kooten</surname><given-names>F.</given-names></name><name><surname>Verhey</surname><given-names>F. R.</given-names></name></person-group> (<year>2002</year>). <article-title>Disease-specific properties of the Rating Scale for Depression in patients with stroke, Alzheimer’s dementia, and Parkinson’s disease.</article-title>
<source/><italic>J. Neuropsychiatry Clin. Neurosci.</italic>
<volume>14</volume>
<fpage>329</fpage>–<lpage>334</lpage>. <pub-id pub-id-type="doi">10.1176/jnp.14.3.329</pub-id>
<pub-id pub-id-type="pmid">12154158</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Natania</surname><given-names>A. C.</given-names></name><name><surname>Alvaro</surname><given-names>V.</given-names></name><name><surname>Masoud</surname><given-names>K.</given-names></name><name><surname>Runa</surname><given-names>B.</given-names></name><name><surname>Kelly</surname><given-names>A. R.</given-names></name><name><surname>David</surname><given-names>F. M.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Developing dimensional, pandiagnostic inhibitory control constructs with self-report and neuropsychological data.</article-title>
<source/><italic>Assessment</italic>
<pub-id pub-id-type="doi">10.1177/1073191118754704</pub-id>
<comment>[Epub ahead of print]</comment>. <pub-id pub-id-type="pmid">29405754</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neumeister</surname><given-names>A.</given-names></name><name><surname>X-Hu</surname><given-names>Z.</given-names></name><name><surname>Luckenbaugh</surname><given-names>D. A.</given-names></name><name><surname>Schwarz</surname><given-names>M.</given-names></name><name><surname>Nugent</surname><given-names>A. C.</given-names></name><name><surname>Bonne</surname><given-names>O.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Differential effects of 5-HTTLPR genotypes on the behavioral and neural responses to tryptophan depletion in patients with major depression and controls.</article-title>
<source/><italic>Arch. Gen. Psychiatry</italic>
<volume>63</volume>
<fpage>978</fpage>–<lpage>986</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.63.9.978</pub-id>
<pub-id pub-id-type="pmid">16953000</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>A.</given-names></name><name><surname>Tam</surname><given-names>W. W.</given-names></name><name><surname>Zhang</surname><given-names>M. W.</given-names></name><name><surname>Ho</surname><given-names>C. S.</given-names></name><name><surname>Husain</surname><given-names>S. F.</given-names></name><name><surname>McIntyre</surname><given-names>R. S.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>IL-1beta, IL-6, TNF- alpha and CRP in elderly patients with depression or Alzheimer’s disease: systematic review and meta-analysis.</article-title>
<source/><italic>Scientific Sci. Reports Rep.</italic>
<volume>8</volume> :<issue>12050</issue>. <pub-id pub-id-type="doi">10.1038/s41598-018-30487-6</pub-id>
<pub-id pub-id-type="pmid">30104698</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norgaard</surname><given-names>M.</given-names></name><name><surname>Ganz</surname><given-names>M.</given-names></name><name><surname>Svarer</surname><given-names>C.</given-names></name><name><surname>Fisher</surname><given-names>P. M.</given-names></name><name><surname>Churchill</surname><given-names>N. W.</given-names></name><name><surname>Beliveau</surname><given-names>V.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Brain networks implicated in seasonal affective disorder: a neuroimaging PET study of the serotonin transporter.</article-title>
<source/><italic>Frontiers Front. in Neuroscience.</italic>
<volume>11</volume>:<issue>614</issue>. <pub-id pub-id-type="doi">10.3389/fnins.2017.00614</pub-id>
<pub-id pub-id-type="pmid">29163018</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nye</surname><given-names>J. A.</given-names></name><name><surname>Purselle</surname><given-names>D.</given-names></name><name><surname>Plisson</surname><given-names>C.</given-names></name><name><surname>Voll</surname><given-names>R. J.</given-names></name><name><surname>Stehouwer</surname><given-names>J. S.</given-names></name><name><surname>Votaw</surname><given-names>J. R.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Decreased brainstem and putamen SERT binding potential in depressed suicide attempters using [11C]-zient PET imaging.</article-title>
<source/><italic>Depress. Anxiety</italic>
<volume>30</volume>
<fpage>902</fpage>–<lpage>907</lpage>. <pub-id pub-id-type="doi">10.1002/da.22049</pub-id>
<pub-id pub-id-type="pmid">23526784</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olivier</surname><given-names>B.</given-names></name><name><surname>Pattij</surname><given-names>T.</given-names></name><name><surname>Wood</surname><given-names>S. J.</given-names></name><name><surname>Oosting</surname><given-names>R.</given-names></name><name><surname>Sarnyai</surname><given-names>Z.</given-names></name><name><surname>Toth</surname><given-names>M.</given-names></name></person-group> (<year>2001</year>). <article-title>The 5-HT<sub>1A</sub> receptor knockout mouse and anxiety.</article-title>
<source/><italic>Behav. Pharmacol.</italic>
<volume>12</volume>
<fpage>439</fpage>–<lpage>450</lpage>. <pub-id pub-id-type="doi">10.1097/00008877-200111000-00004</pub-id><pub-id pub-id-type="pmid">11742137</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oquendo</surname><given-names>M. A.</given-names></name><name><surname>Placidi</surname><given-names>G. P.</given-names></name><name><surname>Malone</surname><given-names>K. M.</given-names></name><name><surname>Campbell</surname><given-names>C.</given-names></name><name><surname>Keilp</surname><given-names>J.</given-names></name><name><surname>Brodsky</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depression.</article-title>
<source/><italic>Arch. Gen. Psychiatry</italic>
<volume>60</volume>
<fpage>14</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.60.1.14</pub-id>
<pub-id pub-id-type="pmid">12511168</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parsey</surname><given-names>R. V.</given-names></name><name><surname>Ogden</surname><given-names>R. T.</given-names></name><name><surname>Miller</surname><given-names>J. M.</given-names></name><name><surname>Tin</surname><given-names>A.</given-names></name><name><surname>Hesselgrave</surname><given-names>N.</given-names></name><name><surname>Goldstein</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Higher serotonin 1A binding in a second major depression cohort: modeling and reference region considerations.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>68</volume>
<fpage>170</fpage>–<lpage>178</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2010.03.023</pub-id>
<pub-id pub-id-type="pmid">20497898</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parsey</surname><given-names>R. V.</given-names></name><name><surname>Oquendo</surname><given-names>M. A.</given-names></name><name><surname>Ogden</surname><given-names>R. T.</given-names></name><name><surname>Olvet</surname><given-names>D. M.</given-names></name><name><surname>Simpson</surname><given-names>N.</given-names></name><name><surname>Huang</surname><given-names>Y. Y.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>59</volume>
<fpage>106</fpage>–<lpage>113</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2005.06.016</pub-id>
<pub-id pub-id-type="pmid">16154547</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>A. T.</given-names></name><name><surname>Jacobs</surname><given-names>R. H.</given-names></name><name><surname>Crane</surname><given-names>N. A.</given-names></name><name><surname>Ryan</surname><given-names>K. A.</given-names></name><name><surname>Weisenbach</surname><given-names>S. L.</given-names></name><name><surname>Ajilore</surname><given-names>O.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Domain-specific impairment in cognitive control among remitted youth with a history of major depression.</article-title>
<source/><italic>Early Intervention Interv. in Psychiatry</italic>
<volume>11</volume>
<fpage>383</fpage>–<lpage>392</lpage>. <pub-id pub-id-type="doi">10.1111/eip.12253</pub-id>
<pub-id pub-id-type="pmid">26177674</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phillips</surname><given-names>M. L.</given-names></name><name><surname>Drevets</surname><given-names>W. C.</given-names></name><name><surname>Rauch</surname><given-names>S. L.</given-names></name><name><surname>Lane</surname><given-names>R.</given-names></name></person-group> (<year>2003</year>). <article-title>Neurobiology of emotion perception I: the neural basis of normal emotion perception.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>54</volume>
<fpage>504</fpage>–<lpage>514</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-3223(03)00168-9</pub-id><pub-id pub-id-type="pmid">12946879</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phillips</surname><given-names>M. L.</given-names></name><name><surname>Ladouceur</surname><given-names>C. D.</given-names></name><name><surname>Drevets</surname><given-names>W. C.</given-names></name></person-group> (<year>2008</year>). <article-title>A neural model of voluntary and automatic emotion regulation: implications for understanding the pathophysiology and neurodevelopment of bipolar disorder.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>13</volume>
<fpage>829</fpage>–<lpage>857</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2008.65</pub-id>
<pub-id pub-id-type="pmid">18574483</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piel</surname><given-names>J. H.</given-names></name><name><surname>Lett</surname><given-names>T. A.</given-names></name><name><surname>Wackerhagen</surname><given-names>C.</given-names></name><name><surname>Plichta</surname><given-names>M. M.</given-names></name><name><surname>Mohnke</surname><given-names>S.</given-names></name><name><surname>Grimm</surname><given-names>O.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>The effect of 5-HTTLPR and a serotonergic multi-marker score on amygdala, prefrontal and anterior cingulate cortex reactivity and habituation in a large, healthy fMRI cohort.</article-title>
<source/><italic>Eur. Neuropsychopharmacol.</italic>
<volume>28</volume>
<fpage>415</fpage>–<lpage>427</lpage>. <pub-id pub-id-type="doi">10.1016/j.euroneuro.2017.12.014</pub-id>
<pub-id pub-id-type="pmid">29358097</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pillai</surname><given-names>R. L. I.</given-names></name><name><surname>Malhotra</surname><given-names>A.</given-names></name><name><surname>Rupert</surname><given-names>D. D.</given-names></name><name><surname>Wechsler</surname><given-names>B.</given-names></name><name><surname>Williams</surname><given-names>J. C.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Relations between cortical thickness, serotonin 1A receptor binding, and structural connectivity: a multimodal imaging study.</article-title>
<source/><italic>Hum. Brain Mapp.</italic>
<volume>39</volume>
<fpage>1043</fpage>–<lpage>1055</lpage>. <pub-id pub-id-type="doi">10.1002/hbm.23903</pub-id>
<pub-id pub-id-type="pmid">29323797</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porter</surname><given-names>R. J.</given-names></name><name><surname>Bourke</surname><given-names>C.</given-names></name><name><surname>Gallagher</surname><given-names>P.</given-names></name></person-group> (<year>2007</year>). <article-title>Neuropsychological impairment in major depression: its nature, origin and clinical significance.</article-title>
<source/><italic>Aust. N. Z. J. Psychiatry</italic>
<volume>41</volume>
<fpage>115</fpage>–<lpage>128</lpage>. <pub-id pub-id-type="doi">10.1080/00048670601109881</pub-id>
<pub-id pub-id-type="pmid">17464689</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quek</surname><given-names>Y. H.</given-names></name><name><surname>Tam</surname><given-names>W. W. S.</given-names></name><name><surname>Zhang</surname><given-names>M. W. B.</given-names></name><name><surname>Ho</surname><given-names>R. C. M.</given-names></name></person-group> (<year>2017</year>). <article-title>Exploring the association between childhood and adolescent obesity and depression: a meta-analysis.</article-title>
<source/><italic>Obesity Obes. Reviews :. an official journal of the International Association for the Study of Obesity</italic>
<volume>18</volume>
<fpage>742</fpage>–<lpage>754</lpage>. <pub-id pub-id-type="doi">10.1111/obr.12535</pub-id>
<pub-id pub-id-type="pmid">28401646</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramage</surname><given-names>A. G.</given-names></name><name><surname>Villalon</surname><given-names>C. M.</given-names></name></person-group> (<year>2008</year>). <article-title>5-hydroxytryptamine and cardiovascular regulation.</article-title>
<source/><italic>Trends in Pharmacological. Sciences Sci.</italic>
<volume>29</volume>
<fpage>472</fpage>–<lpage>481</lpage>.</mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richardson</surname><given-names>J. W.</given-names></name><name><surname>Craige-Jones</surname><given-names>C. P.</given-names></name><name><surname>Nguyen</surname><given-names>T. H.</given-names></name><name><surname>Kung</surname><given-names>H. F.</given-names></name><name><surname>Gardier</surname><given-names>A. M.</given-names></name><name><surname>Dranovsky</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Serotonin-1A autoreceptors are necessary and sufficient for the normal formation of circuits underlying innate anxiety.</article-title>
<source/><italic>Journal J. of Neuroscience.</italic>
<volume>31</volume>
<fpage>6008</fpage>–<lpage>6018</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5836-10.2011</pub-id>
<pub-id pub-id-type="pmid">21508226</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogers</surname><given-names>M. A.</given-names></name><name><surname>Kasai</surname><given-names>K.</given-names></name><name><surname>Koji</surname><given-names>M.</given-names></name><name><surname>Fukuda</surname><given-names>R.</given-names></name><name><surname>Iwanami</surname><given-names>A.</given-names></name><name><surname>Nakagome</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Executive and prefrontal dysfunction in unipolar depression: a review of neuropsychological and imaging evidence.</article-title>
<source/><italic>Neurosci. Res.</italic>
<volume>50</volume>
<fpage>1</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1016/j.neures.2004.05.003</pub-id>
<pub-id pub-id-type="pmid">15288493</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogers</surname><given-names>R. D.</given-names></name><name><surname>Tunbridge</surname><given-names>E. M.</given-names></name><name><surname>Bhagwagar</surname><given-names>Z.</given-names></name><name><surname>Drevets</surname><given-names>W. C.</given-names></name><name><surname>Sahakian</surname><given-names>B. J.</given-names></name><name><surname>Carter</surname><given-names>C. S.</given-names></name></person-group> (<year>2003</year>). <article-title>Tryptophan depletion alters the decision-making of healthy volunteers through altered processing of reward cues.</article-title>
<source/><italic>Neuropsychopharmacology</italic>
<volume>28</volume>
<fpage>153</fpage>–<lpage>162</lpage>. <pub-id pub-id-type="doi">10.1038/sj.npp.1300001</pub-id>
<pub-id pub-id-type="pmid">12496952</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roiser</surname><given-names>J. P.</given-names></name><name><surname>Levy</surname><given-names>J.</given-names></name><name><surname>Fromm</surname><given-names>S. J.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Hasler</surname><given-names>G.</given-names></name><name><surname>Sahakian</surname><given-names>B. J.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>The effect of acute tryptophan depletion on the neural correlates of emotional processing in healthy volunteers.</article-title>
<source/><italic>Neuropsychopharmacology</italic>
<volume>33</volume>
<fpage>1992</fpage>–<lpage>2006</lpage>. <pub-id pub-id-type="pmid">17882232</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romera</surname><given-names>I.</given-names></name><name><surname>Pérez</surname><given-names>V.</given-names></name><name><surname>Menchón</surname><given-names>J. M.</given-names></name><name><surname>Polavieja</surname><given-names>P.</given-names></name><name><surname>Gilaberte</surname><given-names>I.</given-names></name></person-group> (<year>2011</year>). <article-title>Optimal cutoff point of the Hamilton Rating Scale for Depression according to normal levels of social and occupational functioning.</article-title>
<source/><italic>Psychiatry Research Res.</italic>
<volume>186</volume>
<fpage>133</fpage>–<lpage>137</lpage>. <pub-id pub-id-type="doi">10.1016/j.psychres.2010.06.023</pub-id>
<pub-id pub-id-type="pmid">20659770</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rush</surname><given-names>A. J.</given-names></name><name><surname>Trivedi</surname><given-names>M. H.</given-names></name><name><surname>Wisniewski</surname><given-names>S. R.</given-names></name><name><surname>Nierenberg</surname><given-names>A. A.</given-names></name><name><surname>Stewart</surname><given-names>J. W.</given-names></name><name><surname>Warden</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR<sup>∗</sup>D report.</article-title>
<source/><italic>Am. J. Psychiatry</italic>
<volume>163</volume>
<fpage>1905</fpage>–<lpage>1917</lpage>. <pub-id pub-id-type="doi">10.1176/ajp.2006.163.11.1905</pub-id>
<pub-id pub-id-type="pmid">17074942</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryan</surname><given-names>K. A.</given-names></name><name><surname>Vederman</surname><given-names>A. C.</given-names></name><name><surname>Kamali</surname><given-names>M.</given-names></name><name><surname>Marshall</surname><given-names>D.</given-names></name><name><surname>Weldon</surname><given-names>A. L.</given-names></name><name><surname>McInnis</surname><given-names>M. G.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Emotion perception and executive functioning predict work status in euthymic bipolar disorder.</article-title>
<source/><italic>Psychiatry Res.</italic>
<volume>210</volume>
<fpage>472</fpage>–<lpage>478</lpage>. <pub-id pub-id-type="doi">10.1016/j.psychres.2013.06.031</pub-id>
<pub-id pub-id-type="pmid">23870493</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabol</surname><given-names>S. Z.</given-names></name><name><surname>Hu</surname><given-names>S.</given-names></name><name><surname>Hamer</surname><given-names>D.</given-names></name></person-group> (<year>1998</year>). <article-title>A functional polymorphism in the monoamine oxidase A gene promoter.</article-title>
<source/><italic>Hum. Genet.</italic>
<volume>103</volume>
<fpage>273</fpage>–<lpage>279</lpage>. <pub-id pub-id-type="doi">10.1007/s004390050816</pub-id><pub-id pub-id-type="pmid">9799080</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanislow</surname><given-names>C. A.</given-names></name><name><surname>Pine</surname><given-names>D. S.</given-names></name><name><surname>Quinn</surname><given-names>K. J.</given-names></name><name><surname>Kozak</surname><given-names>M. J.</given-names></name><name><surname>Garvey</surname><given-names>M. A.</given-names></name><name><surname>Heinssen</surname><given-names>R. K.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Developing constructs for psychopathology research: research domain criteria.</article-title>
<source/><italic>J. Abnorm. Psychol.</italic>
<volume>119</volume>
<fpage>631</fpage>–<lpage>639</lpage>. <pub-id pub-id-type="doi">10.1037/a0020909</pub-id>
<pub-id pub-id-type="pmid">20939653</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarnyai</surname><given-names>Z.</given-names></name><name><surname>Sibille</surname><given-names>E. L.</given-names></name><name><surname>Pavlides</surname><given-names>C.</given-names></name><name><surname>Fenster</surname><given-names>R. J.</given-names></name><name><surname>McEwen</surname><given-names>B. S.</given-names></name><name><surname>Toth</surname><given-names>M.</given-names></name></person-group> (<year>2000</year>). <article-title>Impaired hippocampal-dependent learning and functional abnormalities in the hippocampus in mice lacking serotonin(1A) receptors.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>97</volume>
<fpage>14731</fpage>–<lpage>14736</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.97.26.14731</pub-id>
<pub-id pub-id-type="pmid">11121072</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sawamura</surname><given-names>J.</given-names></name><name><surname>Ishigooka</surname><given-names>J.</given-names></name><name><surname>Nishimura</surname><given-names>K.</given-names></name></person-group> (<year>2018</year>). <article-title>Re-evaluation of the definition of remission on the 17-item Hamilton Depression Rating Scale based on recovery in health-related quality of life in an observational post-marketing study.</article-title>
<source/><italic>Health and Quality. of Life Outcomes</italic>
<volume>16</volume> :<issue>14</issue>. <pub-id pub-id-type="doi">10.1186/s12955-018-0838-6</pub-id>
<pub-id pub-id-type="pmid">29338728</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schlumpf</surname><given-names>M.</given-names></name><name><surname>Bruinink</surname><given-names>A.</given-names></name><name><surname>Lichtensteiger</surname><given-names>W.</given-names></name><name><surname>Cortes</surname><given-names>R.</given-names></name><name><surname>Palacios</surname><given-names>J. M.</given-names></name><name><surname>Pazos</surname><given-names>A.</given-names></name></person-group> (<year>1987</year>). <article-title>Beta-adrenergic binding sites in fetal rat central nervous system and pineal gland: their relation to other receptor sites.</article-title>
<source/><italic>Developmental Dev. Pharmacology Pharmacol. and Therapeutics.</italic>
<volume>10</volume>
<fpage>422</fpage>–<lpage>435</lpage>. <pub-id pub-id-type="pmid">2824144</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selvaraj</surname><given-names>S.</given-names></name><name><surname>Walker</surname><given-names>C.</given-names></name><name><surname>Arnone</surname><given-names>D.</given-names></name><name><surname>Cao</surname><given-names>B.</given-names></name><name><surname>Faulkner</surname><given-names>P.</given-names></name><name><surname>Cowen</surname><given-names>P. J.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Effect of citalopram on emotion processing in humans: a combined 5-HT<sub>1A</sub> [<sup>11</sup>C]CUMI-101 PET and functional MRI study.</article-title>
<source/><italic>Neuropsychopharmacology</italic>
<volume>43</volume>
<fpage>655</fpage>–<lpage>664</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2017.166</pub-id>
<pub-id pub-id-type="pmid">28776580</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sen</surname><given-names>S.</given-names></name><name><surname>Burmeister</surname><given-names>M.</given-names></name><name><surname>Ghosh</surname><given-names>D.</given-names></name></person-group> (<year>2004a</year>). <article-title>Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits.</article-title>
<source/><italic>American Am. Journal J. of Medical. Genetics Genet. Part B: Neuropsychiatric Neuropsychiatr. Genetics Genet.</italic>
<volume>127B</volume>
<fpage>85</fpage>–<lpage>89</lpage>.</mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Shipley</surname><given-names>W. C.</given-names></name></person-group> (<year>1946</year>). <source/><italic>Institute of Living Scale.</italic>
<publisher-loc>Los Angeles, CA</publisher-loc>: <publisher-name>Western Psychological Services</publisher-name>.</mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siegle</surname><given-names>G. J.</given-names></name><name><surname>Carter</surname><given-names>C. S.</given-names></name><name><surname>Thase</surname><given-names>M. E.</given-names></name></person-group> (<year>2006</year>). <article-title>Use of fMRI to predict recovery from unipolar depression with cognitive behavior therapy.</article-title>
<source/><italic>American Am. Journal J. of Psychiatry</italic>
<volume>163</volume>
<fpage>735</fpage>–<lpage>738</lpage>. <pub-id pub-id-type="pmid">16585452</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>K. A.</given-names></name><name><surname>Morris</surname><given-names>J. S.</given-names></name><name><surname>Friston</surname><given-names>K. J.</given-names></name><name><surname>Cowen</surname><given-names>P. J.</given-names></name><name><surname>Dolan</surname><given-names>R. J.</given-names></name></person-group> (<year>1999</year>). <article-title>Brain mechanisms associated with depressive relapse and associated cognitive impairment following acute tryptophan depletion.</article-title>
<source/><italic>Br. J. Psychiatry</italic>
<volume>174</volume>
<fpage>525</fpage>–<lpage>529</lpage>. <pub-id pub-id-type="doi">10.1192/bjp.174.6.525</pub-id><pub-id pub-id-type="pmid">10616631</pub-id></mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snyder</surname><given-names>H. R.</given-names></name></person-group> (<year>2013</year>). <article-title>Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review.</article-title>
<source/><italic>Psychological Psychol. Bulletin Bull.</italic>
<volume>139</volume>
<fpage>81</fpage>–<lpage>132</lpage>. <pub-id pub-id-type="doi">10.1037/a0028727</pub-id>
<pub-id pub-id-type="pmid">22642228</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spinelli</surname><given-names>S.</given-names></name><name><surname>Chefer</surname><given-names>S.</given-names></name><name><surname>Carson</surname><given-names>R. E.</given-names></name><name><surname>Jagoda</surname><given-names>E.</given-names></name><name><surname>Lang</surname><given-names>L.</given-names></name><name><surname>Heilig</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Effects of early-life stress on serotonin(1A) receptors in juvenile Rhesus monkeys measured by positron emission tomography.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>67</volume>
<fpage>1146</fpage>–<lpage>1153</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2009.12.030</pub-id>
<pub-id pub-id-type="pmid">20172506</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spring</surname><given-names>B.</given-names></name><name><surname>Hitsman</surname><given-names>B.</given-names></name><name><surname>Pingitore</surname><given-names>R.</given-names></name><name><surname>McChargue</surname><given-names>D. E.</given-names></name><name><surname>Gunnarsdottir</surname><given-names>D.</given-names></name><name><surname>Corsica</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Effect of tryptophan depletion on smokers and nonsmokers with and without history of major depression.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>61</volume>
<fpage>70</fpage>–<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2006.03.050</pub-id>
<pub-id pub-id-type="pmid">16893526</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stange</surname><given-names>J. P.</given-names></name><name><surname>Bessette</surname><given-names>K. L.</given-names></name><name><surname>Jenkins</surname><given-names>L. M.</given-names></name><name><surname>Burkhouse</surname><given-names>K. L.</given-names></name><name><surname>Peters</surname><given-names>A. T.</given-names></name><name><surname>Feldhaus</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Attenuated intrinsic connectivity within cognitive control network among individuals with remitted depression: temporal stability and association with negative cognitive styles.</article-title>
<source/><italic>Hum. Brain Mapp.</italic>
<volume>38</volume>
<fpage>2939</fpage>–<lpage>2954</lpage>. <pub-id pub-id-type="doi">10.1002/hbm.23564</pub-id>
<pub-id pub-id-type="pmid">28345197</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Surguladze</surname><given-names>S. A.</given-names></name><name><surname>Elkin</surname><given-names>A.</given-names></name><name><surname>Ecker</surname><given-names>C.</given-names></name><name><surname>Kalidindi</surname><given-names>S.</given-names></name><name><surname>Corsico</surname><given-names>A.</given-names></name><name><surname>Giampietro</surname><given-names>V.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Genetic variation in the serotonin transporter modulates neural system-wide response to fearful faces.</article-title>
<source/><italic>Genes Brain Behav.</italic>
<volume>7</volume>
<fpage>543</fpage>–<lpage>551</lpage>. <pub-id pub-id-type="doi">10.1111/j.1601-183X.2008.00390.x</pub-id>
<pub-id pub-id-type="pmid">18266983</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Surtees</surname><given-names>P. G.</given-names></name><name><surname>Wainwright</surname><given-names>N. W. J.</given-names></name><name><surname>Willis</surname><given-names>S. A. G.</given-names></name><name><surname>Luben-Owen</surname><given-names>R.</given-names></name><name><surname>Day</surname><given-names>N. E.</given-names></name><name><surname>Flint</surname><given-names>J.</given-names></name></person-group> (<year>2006</year>). <article-title>Social adversity, the serotonin transporter (5-HTTLPR) polymorphism and major depressive disorder.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>59</volume>
<fpage>224</fpage>–<lpage>229</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2005.07.014</pub-id>
<pub-id pub-id-type="pmid">16154545</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>H. Y.</given-names></name><name><surname>Callicott</surname><given-names>J. H.</given-names></name><name><surname>Weinberger</surname><given-names>D. R.</given-names></name></person-group> (<year>2008</year>). <article-title>Intermediate phenotypes in schizophrenia genetics redux: is it a no brainer?</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>13</volume>
<fpage>233</fpage>–<lpage>238</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4002145</pub-id>
<pub-id pub-id-type="pmid">18285755</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>B. P.</given-names></name><name><surname>Bruder</surname><given-names>G. E.</given-names></name><name><surname>Stewart</surname><given-names>J. W.</given-names></name><name><surname>McGrath</surname><given-names>P. J.</given-names></name><name><surname>Halperin</surname><given-names>J.</given-names></name><name><surname>Ehrlichman</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Psychomotor slowing as a predictor of fluoxetine nonresponse in depressed outpatients.</article-title>
<source/><italic>Am. J. Psychiatry</italic>
<volume>163</volume>
<fpage>73</fpage>–<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.163.1.73</pub-id>
<pub-id pub-id-type="pmid">16390892</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teasdale</surname><given-names>J. D.</given-names></name><name><surname>Dent</surname><given-names>J.</given-names></name></person-group> (<year>1987</year>). <article-title>Cognitive vulnerability to depression: an investigation of two hypotheses.</article-title>
<source/><italic>Br. J. Clin. Psychol.</italic>
<volume>26(Pt 2)</volume>
<fpage>113</fpage>–<lpage>126</lpage>. <pub-id pub-id-type="doi">10.1111/j.2044-8260.1987.tb00737.x</pub-id>
<pub-id pub-id-type="pmid">3580646</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trivedi</surname><given-names>M. H.</given-names></name><name><surname>Rush</surname><given-names>A. J.</given-names></name><name><surname>Wisniewski</surname><given-names>S. R.</given-names></name><name><surname>Nierenberg</surname><given-names>A. A.</given-names></name><name><surname>Warden</surname><given-names>D.</given-names></name><name><surname>Ritz</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Evaluation of outcomes with citalopram for depression using measurement-based care in STAR<sup>∗</sup>D: implications for clinical practice.</article-title>
<source/><italic>Am. J. Psychiatry</italic>
<volume>163</volume>
<fpage>28</fpage>–<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.163.1.28</pub-id>
<pub-id pub-id-type="pmid">16390886</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Veen</surname><given-names>F. M.</given-names></name><name><surname>Evers</surname><given-names>E. A. T.</given-names></name><name><surname>Deutz</surname><given-names>N. E. P.</given-names></name><name><surname>Schmitt</surname><given-names>J. A. J.</given-names></name></person-group> (<year>2007</year>). <article-title>Effects of acute tryptophan depletion on mood and facial emotion perception related brain activation and performance in healthy women with and without a family history of depression.</article-title>
<source/><italic>Neuropsychopharmacology</italic>
<volume>32</volume>
<fpage>216</fpage>–<lpage>224</lpage>. <pub-id pub-id-type="doi">10.1038/sj.npp.1301212</pub-id>
<pub-id pub-id-type="pmid">17019406</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Vickers</surname><given-names>S. P.</given-names></name><name><surname>Dourish</surname><given-names>C. T.</given-names></name></person-group> (<year>2004</year>). <article-title>Serotonin receptor ligands and the treatment of obesity.</article-title>
<source/><italic>Current Curr. Opinion Opin. in Investigational. Drugs</italic> (<publisher-loc>London, England</publisher-loc> : <comment>2000</comment>) <volume>5</volume>
<fpage>377</fpage>–<lpage>388</lpage>.</mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villafuerte</surname><given-names>S. M.</given-names></name><name><surname>Vallabhaneni</surname><given-names>K.</given-names></name><name><surname>Sliwerska</surname><given-names>E.</given-names></name><name><surname>McMahon</surname><given-names>F. J.</given-names></name><name><surname>Young</surname><given-names>E. A.</given-names></name><name><surname>Burmeister</surname><given-names>M.</given-names></name></person-group> (<year>2009</year>). <article-title>SSRI response in depression may be influenced by SNPs in HTR1B and HTR1A.</article-title>
<source/><italic>Psychiatr. Genet.</italic>
<volume>19</volume>
<fpage>281</fpage>–<lpage>291</lpage>. <pub-id pub-id-type="doi">10.1097/YPG.0b013e32832a506e</pub-id>
<pub-id pub-id-type="pmid">19829169</pub-id></mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Votruba</surname><given-names>K. L.</given-names></name><name><surname>Langenecker</surname><given-names>S. A.</given-names></name></person-group> (<year>2013</year>). <article-title>Age- and education-based normative data for the parametric Go/No-go task.</article-title>
<source/><italic>J. Clin. Exp. Neuropsychol.</italic>
<volume>32</volume>
<fpage>132</fpage>–<lpage>146</lpage>. <pub-id pub-id-type="doi">10.1080/13803395.2012.758239</pub-id>
<pub-id pub-id-type="pmid">23289626</pub-id></mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Webb</surname><given-names>C. A.</given-names></name><name><surname>Dillon</surname><given-names>D. G.</given-names></name><name><surname>Pechtel</surname><given-names>P.</given-names></name><name><surname>Goer</surname><given-names>F. K.</given-names></name><name><surname>Murray</surname><given-names>L.</given-names></name><name><surname>Huys</surname><given-names>Q. J.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Neural correlates of three promising endophenotypes of depression: evidence from the EMBARC study.</article-title>
<source/><italic>Neuropsychopharmacology</italic>
<volume>41</volume>
<fpage>454</fpage>–<lpage>463</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2015.165</pub-id>
<pub-id pub-id-type="pmid">26068725</pub-id></mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wessa</surname><given-names>M.</given-names></name><name><surname>Lois</surname><given-names>G.</given-names></name></person-group> (<year>2015</year>). <article-title>Brain functional effects of psychopharmacological treatment in major depression: a focus on neural circuitry of affective processing.</article-title>
<source/><italic>Current Curr. Neuropharmacology Neuropharmacol.</italic>
<volume>13</volume>
<fpage>466</fpage>–<lpage>479</lpage>. <pub-id pub-id-type="doi">10.2174/1570159X13666150416224801</pub-id>
<pub-id pub-id-type="pmid">26412066</pub-id></mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wijaya</surname><given-names>C. S.</given-names></name><name><surname>Lee</surname><given-names>J. J. Z.</given-names></name><name><surname>Husain</surname><given-names>S. F.</given-names></name><name><surname>Ho</surname><given-names>C. S. H.</given-names></name><name><surname>McIntyre</surname><given-names>R. S.</given-names></name><name><surname>Tam</surname><given-names>W. W.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Differentiating medicated patients suffering from major depressive disorder from healthy controls by spot urine measurement of monoamines and steroid hormones.</article-title>
<source/><italic>International Int. Journal J. of Environmental. Research Res. and Public Health</italic>
<volume>15</volume> :<issue>E865</issue>. <pub-id pub-id-type="doi">10.3390/ijerph15050865</pub-id>
<pub-id pub-id-type="pmid">29701669</pub-id></mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wojnar</surname><given-names>M.</given-names></name><name><surname>Brower</surname><given-names>K. J.</given-names></name><name><surname>Strobbe</surname><given-names>S.</given-names></name><name><surname>Ilgen</surname><given-names>M.</given-names></name><name><surname>Matsumoto</surname><given-names>H.</given-names></name><name><surname>Nowosad</surname><given-names>I.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Association between Val66Met brain-derived neurotrophic factor (BDNF) gene polymorphism and post-treatment relapse in alcohol dependence.</article-title>
<source/><italic>Alcohol. Clin. Exp. Res.</italic>
<volume>33</volume>
<fpage>693</fpage>–<lpage>702</lpage>. <pub-id pub-id-type="doi">10.1111/j.1530-0277.2008.00886.x</pub-id>
<pub-id pub-id-type="pmid">19170664</pub-id></mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wood</surname><given-names>R. M.</given-names></name><name><surname>Rilling</surname><given-names>J. K.</given-names></name><name><surname>Sanfey</surname><given-names>A. G.</given-names></name><name><surname>Bhagwagar</surname><given-names>Z.</given-names></name><name><surname>Rogers</surname><given-names>R. D.</given-names></name></person-group> (<year>2006</year>). <article-title>Effects of tryptophan depletion on the performance of an iterated Prisoner’s Dilemma game in healthy adults.</article-title>
<source/><italic>Neuropsychopharmacology</italic>
<volume>31</volume>
<fpage>1075</fpage>–<lpage>1084</lpage>. <pub-id pub-id-type="doi">10.1038/sj.npp.1300932</pub-id>
<pub-id pub-id-type="pmid">16407905</pub-id></mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yasuno</surname><given-names>F.</given-names></name></person-group> (<year>2004</year>). <article-title>[Hippocampal serotonin 1A receptor and memory function].</article-title>
<source/><italic>Seishin Shinkeigaku Zasshi</italic>
<volume>106</volume>
<fpage>1314</fpage>–<lpage>1322</lpage>.<pub-id pub-id-type="pmid">15669228</pub-id></mixed-citation>
</ref>
<ref id="B148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeo</surname><given-names>S. N.</given-names></name><name><surname>Zainal</surname><given-names>H.</given-names></name><name><surname>Tang</surname><given-names>C. S.</given-names></name><name><surname>Tong</surname><given-names>E. M.</given-names></name><name><surname>Ho</surname><given-names>C. S.</given-names></name><name><surname>Ho</surname><given-names>R. C.</given-names></name></person-group> (<year>2017</year>). <article-title>Success/failure condition influences attribution of control, negative affect, and shame among patients with depression in Singapore.</article-title>
<source/><italic>BMC Psychiatry</italic>
<volume>17</volume>:<issue>285</issue>. <pub-id pub-id-type="doi">10.1186/s12888-017-1451-7</pub-id>
<pub-id pub-id-type="pmid">28768488</pub-id></mixed-citation>
</ref>
<ref id="B149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>J.</given-names></name><name><surname>Lim</surname><given-names>H. Y.</given-names></name><name><surname>Abdullah</surname><given-names>F.</given-names></name><name><surname>Chan</surname><given-names>H. M.</given-names></name><name><surname>Mahendran</surname><given-names>R.</given-names></name><name><surname>Ho</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Directional associations between memory impairment and depressive symptoms: data from a longitudinal sample and meta-analysis.</article-title>
<source/><italic>Psychol. Med.</italic>
<volume>48</volume>
<fpage>1664</fpage>–<lpage>1672</lpage>. <pub-id pub-id-type="doi">10.1017/S0033291717003154</pub-id>
<pub-id pub-id-type="pmid">29113607</pub-id></mixed-citation>
</ref>
<ref id="B150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zanderigo</surname><given-names>F.</given-names></name><name><surname>Pantazatos</surname><given-names>S.</given-names></name><name><surname>Rubin-Falcone</surname><given-names>H.</given-names></name><name><surname>Ogden</surname><given-names>R. T.</given-names></name><name><surname>Chhetry</surname><given-names>B. T.</given-names></name><name><surname>Sullivan</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>In vivo relationship between serotonin 1A receptor binding and gray matter volume in the healthy brain and in major depressive disorder.</article-title>
<source/><italic>Brain Structure Struct. and Function.</italic>
<volume>223</volume>
<fpage>2609</fpage>–<lpage>2625</lpage>. <pub-id pub-id-type="doi">10.1007/s00429-018-1649-6</pub-id>
<pub-id pub-id-type="pmid">29550938</pub-id></mixed-citation>
</ref>
<ref id="B151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Guadarrama</surname><given-names>L.</given-names></name><name><surname>Corona-Morales</surname><given-names>A. A.</given-names></name><name><surname>Vega-Gonzalez</surname><given-names>A.</given-names></name><name><surname>Rocha</surname><given-names>L.</given-names></name><name><surname>Escobar</surname><given-names>A.</given-names></name></person-group> (<year>2006</year>). <article-title>Rats subjected to extended L-tryptophan restriction during early postnatal stage exhibit anxious-depressive features and structural changes.</article-title>
<source/><italic>J. Neuropathol. Exp. Neurol.</italic>
<volume>65</volume>
<fpage>562</fpage>–<lpage>570</lpage>. <pub-id pub-id-type="doi">10.1097/00005072-200606000-00004</pub-id>
<pub-id pub-id-type="pmid">16783166</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>